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The peptide transporter-1, PepT1, is responsible for the uptake 
of peptides in the mammalian intestine after protein digestion. It has 
also been shown to transport a wide range of pharmacological agents; 
thus making it important in drug design and delivery. Many studies 
have addressed structure-function relationships in the transporter, 
using biochemical and uptake assays; however PepT1 is an 
electrogenic transporter whose activities could be more clearly studied 
using electrophysiological methods. 
In this work therefore, the transporter has been studied using 
the two electrode voltage clamp technique on the transporter 
expressed in Xenopus laevis oocytes. 
Temperature effects on the kinetics of the three isoforms 
studied (rabbit, zebrafish, seabass) is reported here with a suggestion 
of a possible structural adaptation in the transporter. Since the 
transporter is also of interest in animal feed formulation, transport 
characteristics of a range of dipeptide combinations are also 
presented; with a recommendation on the possible optimal lysine 
supplementation in feeds that require essential amino acids 
supplementation. 
Reverse operation in transporters may be the result of or lead 
to pathophysiological states. Experimental data here show that 
mutants in Arginine 282 and aspartate 341 exhibit properties that 
make them suitable as models to study possible reverse operation in 
























CHAPTER 1 INTRODUCTION 
 
1.1 Transport and transporters 
 
The human body is a complex organization of inter-connected 
cells, tissues and organs that perform different, yet inter-dependent 
functions; with the ultimate goal of preserving life. Of necessity 
therefore is the need to exchange and move substances and molecules 
from one part of the system to another. This has given rise to diverse 
transport systems within the organism. The movement of molecules in 
and out of the cell is an integral part of cellular homeostasis, this 
movement is usually facilitated by membrane proteins which, based 
on operational mechanisms, are classified as transporters or ion 
channels or pumps (Braun, 2009).   
Transporters typically move an ion down its electrochemical 
gradient and then harness the free energy associated with this process 
to facilitate the trans-membrane movement of another ion or organic 
molecule (e.g. glucose, bicarbonate, neurotransmitter, amino acid, 
peptides etc.) in either the same or opposite direction. 
Sometimes, the movement of the co-transported substance may 
be against its cellular concentration gradient; thereby allowing a cell 
to either accumulate or export a given ion or compound. 
Mechanistically, transporters typically undergo a cycle of 





binding sites on each site of the membrane is controlled by gates that 
sequentially open and close(Braun, 2009). 
Transporters are ubiquitous proteins and as such subserve 
different cellular organizations and systems. Among the different 
types of transporters is the peptide transporter -1 (PepT1), a 
transporter which functions primarily in the movement of the products 
of protein digestion, i.e. peptides. 
1.2 Protein digestion and absorption 
1.2.1 Gastric phase 
The digestion of dietary protein begins in the stomach where 
proteolysis is initiated by two types of pepsins (Freeman & Kim Y.S., 
1978;Van, 1989b). These are the major gastric proteases that are 
autocatalytically activated from zymogen precursors at acidic pH. The 
action of these enzymes results in a mixture of large polypeptides, 
smaller polypeptides and some free amino acids. These hydrolytic 
products may influence a number of gastric functions  that are under 
hormonal control such as secretion of acid and pepsinogen, rate of 
gastric emptying, and control of the pyloric sphincter (Freeman & 
Kim Y.S., 1978)  The gastric phase may however not play a critical 
role in protein digestion since patients with total gastrectomy can 
digest and assimilate dietary protein with little apparent difficulty 







1.2.2 Pancreatic phase 
In normal individuals, the pancreatic phase of protein digestion 
is important in converting the ingested protein to a mixture of small 
oligopeptides and free amino acids. This is accomplished by several 
proteolytic enzymes synthesized and released by pancreatic acinar 
cells as inactive zymogens. These enzymes are activated in the 
duodenum, where the rise in pH to neutral or slightly alkaline 
conditions inactivates the gastric pepsins.  
Activation of the pancreatic proenzymes is initiated by 
enteropeptidase, an enzyme associated with the brush border 
membrane and localized to the duodenal enterocytes. Its only known 
function is to activate trypsin thereby initiating a cascade of 
proteolytic events that results in fully activated trypsin, chymotrypsin, 
elastase and carboxypeptidases A and B (Rinderknecht, 1986). 
These three enzymes have a serine amino acid residue at their 
active site and thus are collectively classified as serine proteases. 
Trypsin cleaves peptide bonds on the carboxyl side of basic amino 
acids (Arginine, Lysine), while chymotrypsin favors bonds where the 
carbonyl group is aromatic (Tyrosine, Trptophan). Elastase hydrolyzes 
elastin and cleaves bonds in polypeptides where the amino acid 
residue contributing the carboxyl group is aliphatic (Alanine, Leucine, 
Glycine, Valine, Isoleucine). Carboxypeptidases A and B are the 
major exopeptidases found in pancreatic secretions. Both are zinc-
containing metallopeptidases of defined specificity in removing  






The specificities of the five pancreatic proteases are 
complementary to one another (Van, 1989a); as a result the majority 
of proteins are reduced to a mixture of free amino acids and 
oligopeptides (Alpers, 2012) that account for approximately 40%  and 
60% of the total luminal α-amino nitrogen respectively (Chung et al., 
1979;Freeman & Kim Y.S., 1978)). Thus the pancreatic phase of 
digestion is more critical than the gastric phase for effective protein 
assimilation in humans. 
1.2.3 Small Intestine Phase 
Previously it was believed that dietary proteins were rapidly 
and completely digested by the actions of gastric and pancreatic 
proteases. Thus the primary function of the small intestine epithelium 
was thought to be solely involved with amino acid absorption and 
transport to the portal blood. However, it is now known that the final 
steps in the digestion of peptides take place in the intestinal lumen and 
are associated with small intestine mucosal cells.  
These cells are highly polarized and present to the intestinal 
lumen a brush border membrane containing a number of peptidases 
that participate in the final phases of protein digestion. These 
peptidases are usually dimeric, integral membrane proteins attached 
by either a hydrophobic membrane-spanning segment or, in at least 
one instance, by covalent attachment to glycosyl-phosphatidyl-inositol 
(Matsumoto et al., 1989). The active site is associated with a large 






These enzymes are translated and synthesized in the rough 
endoplasmic reticulum, glycosylated in the Golgi membranes, and 
specifically inserted into the brush border membrane (Semenza, 
1986). Probably the most abundant peptidase is aminopeptidase N, 
which sequentially removes the N-terminal amino acids from short 
oligopeptides. Interestingly, the intestinal brush border membrane 
contains at least four peptidases that have high hydrolytic rates with 
peptides containing a proline residue at the site of cleavage. 
Dipeptidyl aminopeptidase IV and aminopeptidase P cleave prolyl 
peptides from the amino terminus, while angiotensin-converting 
enzyme and carboxypeptidase P work in a concerted fashion to 
hydrolyze prolyl peptides from the carboxy terminal end (Yoshioka et 
al., 1988). 
The specificities of these enzymes are believed to be 
complementary to those of pancreatic proteases, which have little or 
no ability to hydrolyze peptide bonds involving proline. The brush 
border membrane also contains several neutral metallopeptidases 
(Guan et al., 1988) that cleave the interior peptide bonds of relatively  
large proteins and polypeptides but are different from the pancreatic 
endopeptidases discussed above. These enzymes can initiate the 
hydrolysis of relatively large proteins such as α-casein, fibrinogen and 
histone, this reduces them to small peptides and amino acids even 
without  the action of pancreatic proteases (Guan et al., 1988). 
The collective result of the action of the gastric, pancreatic, 
and brush border membrane proteases is to reduce the majority of 





tripeptides, which thereby makes it available to the various carrier-
transporters of the brush border membrane. 
1.2.4 Transport and absorption phase: amino acid 
transporters 
Transfer of amino acids across the hydrophobic domain of the 
plasma membrane is mediated by proteins that recognize, bind, and 
transport these amino acids from the extracellular medium into the 
cell, or vice versa (Palacín et al., 1998). These proteins are known as 
amino acid transporters, and they vary in nomenclature based on the 
specific amino acid types they transport. Current analysis (Hediger et 
al., 2004) of the SLC families identifies, in mammals, 59 functional 
amino acid transport proteins that are grouped into 12 separate SLC 
families. Orphan transporters are present in many of these families, 
suggesting that the total number of mammalian amino acid transport 
proteins is actually much greater than the 59 identified to date 
(Thwaites & Anderson, 2011) 
1.2.5 Transport and absorption phase: peptide 
transporters 
While the body of knowledge detailing absorption of amino 
acids is relatively recent in terms of full scientific acceptance, the 
absorption of peptides as an established biological concept on the 
other end is quite old. The first evidence  for peptide transport was 
provided in the 1950s (Newey & Smyth, 1957;Newey & Smyth, 
1959).Today, it is universally accepted that the primary route of 





(PepT1). In addition to transport through PepT1, peptides may also be 
absorbed through alternate routes including paracellular movement 
and by cell-penetrating peptides (CPP) that are capable of moving 
cargo across the plasma membrane(Gilbert et al., 2008). 
1.3 The Peptide transporter-1 (PepT1) 
1.3.1 Journey of discovery 
Multiple research groups had independently identified a 
peptide transporter expressed in the basolateral membrane of 
enterocytes that was responsible for movement of peptides from inside 
the cell to the portal circulation. This kind of transporter is different 
from other peptide transporters, expressed on the apical, luminal 
surface and which is responsible for moving dipeptides from the 
lumen into the enterocytes. It had even been suggested, though not 
proven, that the enterocyte contained high concentrations of intra-
cellular peptidases that hydrolyzed peptides into their constituent 
amino acids (AA) resulting in only free AA transport out of the cell.  
Then, in 1974, Kim and co-workers (Kim et al., 1974) detected 
peptidase activity in the brush border and soluble fractions of rat 
intestinal mucosa for 13 dipeptides and 5 tripeptides with the soluble 
fractions constituting 80 to 90% and brush border constituting 10 to 
15% of total activity. The authors acknowledged that significant cross-
contamination of each fraction occurred and lability of the peptide 
hydrolases prevented further purification and functional 
characterization of specific enzymes. Although these data 





demonstrated complete hydrolysis of all dietary protein-derived 
peptides. Inside the cell, peptides may be hydrolyzed into free AA by 
peptidases and transported across the basolateral membrane by free 
AA transporters, or intact peptides may be transported out of the cell 
by a peptide transporter. 
The discovery of a peptide transporter in the basolateral 
membrane of enterocytes (Terada et al., 1999) and the knowledge that 
some peptides are relatively resistant to hydrolysis provides at least 
presumptive evidence that a carrier-mediated mechanism exists for 
transport of intact peptides to the bloodstream. In recent years, peptide 
transport from inside the cell to the basolateral compartment has been 
studied to evaluate transport characteristics of the basolateral peptide 
transporter.  
Although results from many studies demonstrated uptake of 
peptides into intestinal cells, the transporter responsible for peptide 
uptake was not identified until the 1990s. In 1994, the first PepT1 
mRNA was cloned from the rabbit (Fei et al., 1994).The PepT1 
(SLC15) was cloned by microinjecting mRNA isolated from rabbit 
intestine into Xenopus oocytes resulting in functional expression of 
the protein, predicted to consist of 12 transmembrane domains (Boll et 
al., 1994;Fei et al., 1994) 
1.3.2  Characterization 
The first characterization of the peptide transporter in a 
livestock animal was reported by Matthews and co-workers; in which 





in Xenopus oocytes and dipeptide transport was demonstrated 
(Matthews et al., 1996). They observed that Gly-Sar uptake was 
saturatable (Kt = 0.4 mM) and inhibited 44% by carnosine, 94% by 
methionylglycine, and 91% by glycylleucine, but not by free glycine. 
The presence of mRNA that encodes for a peptide transporter in sheep 
omasal epithelia was confirmed by (Pan et al., 1997) when they 
demonstrated transport for di- and tripeptides in oocytes injected with 
poly(A)+ RNA. 
1.3.3 Classification and species isoforms 
The mammalian peptide transporter proteins are part of the 
Proton-coupled Oligopeptide Transporter (POT) superfamily (SLC15) 
which is also called Peptide Transporter (PTR) family (Steiner et al., 
1995). The characteristics of each family member are summarized in 
Table 1.1. 
The peptide transporter, PepT1, has been cloned in multiple 
vertebrate species including the rabbit, rat, mouse, sheep, chicken, 
turkey, dog, human, pig, cattle, monkey, Atlantic cod, zebra fish and 
seabass.  The size of PepT1 ranges from 707 to 729 AA. Expression 
or activity, or both, of PepT1 has been detected in other species 
including the guinea pig (Himukai et al., 1983), hamster (Burston & 
Matthews, 1990), and the black bear (Gilbert et al., 2007). Peptide 
transporters have also been found in bacteria, yeast, plants, and 
invertebrates (Daniel, 2004). Recently, a prokaryotic H+-dependent 
peptide transporter, YdgR, was characterized and found to have 






Table 1.1: The SLC15 family (Adapted from (Daniel & Kottra, 2003)) 
 
1.4 PepT1: structure-function relationships 
1.4.1 Membrane topology 
An in-depth analysis of the structure of the PEPT protein has 
not been performed. However, an epitope insertion study suggests that 
the membrane topology model predicted by the hydropathicity 
analysis of the amino acidic sequence may be correct (Covitz et al., 
1998). The membrane topology is shown in figure 1.1. 
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Fig. 1.1 Membrane topology model of PEPT1. Protein domains and 
individual amino acid residues that have been identified as relevant in 
determining the functional characteristics of the protein are marked in 
colours. Predicted protein kinase recognition domains and 
glycosylation sites have not been included, since their relevance has 
not been proven experimentally. (Source: (Daniel & Kottra, 2003) 
1.4.2 Stoichiometry and kinetics 
To study the proton-to-peptide stoichiometry and the 
dependence of the kinetic parameters on extracellular pH, Steel and co 
(1997) employed uptake studies of radiolabelled neutral and charged 
dipeptides and reported that PepT1 did not display the substrate-gated 
anion conductances that have been found to be characteristic of 
members of the Na+- and H+-coupled high-affinity glutamate  





entirely due to H+ movement (Steel et al., 1997). In addition, they 
concluded that the rate of acidification, the initial rates of the uptake 
of radiolabelled peptides and the associated charge fluxes gave 
proton-substrate coupling ratios of 1:1, 2:1 and 1:1 for neutral, acidic 
and basic dipeptides, respectively.  They also showed that at 
physiological pH (pH 5.5-6.0) PepT1 prefers  neutral and acidic 
peptides(Steel et al., 1997). 
1.4.3 Critical amino acid residues 
A variety of single point mutations has been introduced into 
PEPT1 and PEPT2 and have led to the identification of some essential 
and critical residues. Of central importance for PEPT1 activity is the 
extracellular histidine residue (H57) on the interface of the second 
transmembrane domain and the extracellular side (Figure 1.1) (Chen 
et al., 2000;Fei et al., 1997;Terada et al., 1996). PEPT1 was shown to 
be inactivated efficiently by diethlypyrocarbonate as a histidine-
modifying agent (Terada et al., 1996) and mutation of H57 led to a 
completely inactive transporter (Fei et al., 1997). The adjacent 
tyrosine residue (Y56) was also shown to be involved in substrate 
interaction by a reduction in the affinity for differently charged 
dipeptides when mutated to a phenylalanine (Chen et al., 2000).  
Another tyrosine residue predicted to lie in the second 
transmembrane domain (Y64) also appears to be involved in substrate 
translocation since the subtle change to a phenylalanine residue almost 
abolished transport (Chen et al., 2000). Moreover, Y167 in the fifth 
transmembrane domain and part of the PTR-family signature motif 





view of the pH dependence of the transporters, additional histidine 
residues such as H111 and H121 and H260 have also been mutated, 
but did not yield convincing evidence for an essential role in the 
transport process (Chen et al., 2000;Fei et al., 1997). 
1.5 Insights from a prokaryote homologue 
1.5.1 Crystal structure 
In 2010, Newstead and coworkers reported the crystal structure 
of a peptide transporter (PeptSo) from the bacterium Shewanella 
oneidensis (Newstead et al., 2011). It shows a high degree of sequence 
conservation within the TM region (~30% identity) to the mammalian 
PepT1 and PepT2 proteins. All previously identified residues 
proposed to be functionally important in the mammalian transporters 
are conserved, including a critical histidine residue. 
PepTSo contains 14 TM helices (Figure 1.2A), the N- and C-
terminal six-helix bundles, formed by helices H1–H6 and H7–H12, 
come together to form a ‗V‘-shaped transporter, related by a pseudo 
two-fold symmetry axis running perpendicular to the membrane plane. 
PepTSo has two additional TM helices, HA and HB, which are 
inserted into the cytoplasmic loop connecting the N- and C-terminal 
bundles. These form a hairpin-like structure in the membrane that 






Figure 1.2: Structure of PepTSo. (A) PepTSo topology. The central 
and extracellular cavities are shown as a closed diamond and open 
triangle, respectively. A bound ligand in the central cavity is 
represented as a black horizontal bar. (B) PepTSo structure viewed in 
the plane of the membrane. The two hydrophilic cavities present in the 
structure are outlined in dashed lines. The hydrophobic core of the 
membrane (pale yellow) is distinguished from the interfacial region 
(light grey). N and C represent the N- and C-termini, respectively. 
Bound ligand is shown in black. Helices are labeled. (C) View from 
the extracellular side of the membrane. (Source: (Newstead et al., 
2011) 
The apparent KM for transport of the hydrolysis resistant di-
peptide glycylsarcosine is 1.5±0.15 mM, similar to the value reported 
for human PepT1 of 1.1±0.1 mM (Brandsch et al., 1994) (Figure 
1.3A). Uptake of a fluorescent di-peptide, β-Ala-Lys-Ne-7-amino-4-





overexpressing the PepTSo gene was reduced upon addition of either 
di- or tri-alanine peptides to the media. Addition of L-alanine or the 
larger tetra-alanine peptide, however, had little effect, suggesting a 
similar preference for di- and tri-peptides as reported for the 
mammalian transporters (Fei et al, 1994).  
Uptake was also abolished by the proton ionophore carbonyl 
cyanide p-chlorophenylhydrazone, consistent with a dependence on 















1.5.2 Transport mechanism 
The mode of transport is depicted in figure 1.3 
 
Figure 1.3: Transport of peptides by PepTSo. (A). Concentration dependence of 
PepTSo-mediated glycylsarcosine (Gly-Sar) uptake in E. coli. Results shown, 
expressed per milligram of His-tagged PepTSo protein, are mean values ± s.d. 
(n=4). (B) Effect on transport activity of mutating His61 to cysteine. Uptake of 
[3H]-glycylsarcosine (Gly-Sar) over a period of 10 min was measured in E. coli 
cells expressing the indicated forms of His-tagged PepTSo or in control cells lacking 
the transporter. Results shown are mean values ± s.d. (n=3) and are expressed per 
milligram dry weight of bacteria. The inset shows western blots of equivalent 
samples from each culture, stained with a monoclonal antibody against 
oligohistidine. (C) Extracellular cavity viewed in the membrane plane. The central 
and extracellular cavities are isolated from each other by a putative extracellular 
gate. Residues in the central and extracellular cavities are highlighted in red and 
yellow, respectively. His61, part of the proposed proton–substrate coupling 
machinery is shown in green. Bound ligand is shown as a black CPK model of a di-
alanine peptide. (D) Intracellular gate viewed in the membrane plane. Residues 
forming the gate are shown as stick models with transparent CPK surfaces. LacY 
helices (grey) are superposed onto PepTSo. Bound ligand is shown as a black CPK 





1.5.3 The peptide-binding site 
As previously noted, many of the residues conserved between 
PepTSo and the mammalian peptide transporters cluster around the 
central hydrophilic cavity, with approximate dimensions of 13 × 12 × 
11 Å (Figure 1.4). These dimensions are sufficient to accommodate 
both di- and tri-peptides, although would be sterically restrictive for 
larger tetra-peptide ligands. According to (Newstead et al., 2011) the 
dimensions of the cavity could explain the lack of affinity for single 
amino acids, as these would presumably be incapable of interacting 
sufficiently with both the N- and C-terminal domains of the 
transporter.  
 
Figure 1.4: The peptide-binding site. Stereo view of the central cavity as 
viewed from above on the extracellular side of the membrane. Conserved 
residues between PepTSo and the mammalian peptide transporters are 
labelled and coloured according to side-chain type, Arg and Lys (blue), Glu 
and Ser (red), Tyr (green) and Trp, Phe and Leu (cyan). A di-peptide sized 
Cα baton (orange) is fitted as a size reference into the mFo -DFc electron 






The binding site is formed by residues from helices H1, H2, 
H4 and H5 from the N-terminal six-helix bundle and from helices H7, 
H8, H10 and H11 from the C-terminal bundle. On the N-terminal side 
of the binding site, three conserved positively charged residues, 
Arg25(27), Arg32(34) and Lys127(140) extend into the cavity. The 
numbers in brackets represent the location of the same residues in the 
human isoform. It has been reported that mutation of Arg25(27) in 
human PepT2 to a histidine completely inactivates transport (Terada 
et al, 2004). Two conserved tyrosine residues, Tyr29(31) and 
Tyr68(64), are positioned close to this positively charged cluster. On 
the C-terminal side of the binding site, at a distance of ~13 Å from 
Lys127(140), are two further strictly conserved residues, Glu419(595) 
and Ser423(599), located in close proximity to Tyr154(167).  
Various mutants of Glu419(595) in PepT1 have been reported 
to drastically reduce transport activity, except where mutation was to 
an aspartic acid (Xu et al., 2009), indicating the importance of a 
negatively charged residue at this position. The arrangement of 
opposite charges within the binding site may have an important role in 
the recognition and orientation of peptides through the creation of a 
dipole moment. The presence of several possible hydrogen-bond 
donors and acceptors could be advantageous in adapting to peptides of 
various lengths, sequences and charges.  
Most of the other residues in the binding site are conserved 
hydrophobic residues, including Ile157(170), Trp312(294), 
Phe315(297) and Trp446(622). These residues are likely to provide a 





hydrophobic than the peptide backbone. This idea is supported by the 
fact that mutation of Trp312(294) of PepT1 to alanine reduces 
substrate uptake in HEK293 cells (Bolger et al., 1998)(Bolger et al, 
1998).  
Interestingly, some conserved residues are not located within 
the central cavity. The PTR2_1 motif, also conserved throughout the 
POT family (Daniel et al, 2006), spans the cytoplasmic linker 
connecting helices H2 and H3 (Newstead et al., 2011). Residues 
within this motif do not make any contribution to the interior of the 
protein and most likely sit in the interfacial region of the lipid bilayer, 
a location also suggested by the coarse-grained MD simulations. 
Glu21(23) and Glu24(26) on helix H1 are also well conserved among 
the POTs. These residues are not located in the peptide-binding site 
but are in close proximity to Arg25(27) and Lys127(140), and may 











1.5.4 Transport model 
Figure 1.5 summarizes a possible model for transport. 
 
 
Figure 1.5: A possible mechanism for peptide–proton symport. (A) Outward-
facing state: peptide (Pep) and proton (H
+
) can access respective binding 
sites through the outward-facing cavity that is open towards the 
extracellular side of the membrane. The peptide-binding site is made from 
the surfaces of both the N- and C-terminal helix bundles (indicated by + and 
− signs), whereas the proton-binding site is located in the area close to the 
extracellular gate. (B) Occluded state: both ends of the central cavity are 
closed with peptide occluded into the central cavity. The proton-binding site 
is still exposed to the extracellular side through the extracellular cavity. (C) 
Inward-facing state: peptide and proton are released on the intracellular 
side of the membrane through the inward-facing cavity. Note that the 







1.5.5 Regulation of transport activity 
The transport activity of PEPT1 can be modulated to meet 
physiological needs by regulation at either the transcriptional level or 
by the translocation of preformed transporter proteins to the cell 
surface. The latter has been shown to occur in response to acute 
insulin or leptin treatment or prolonged exposure to dipeptides in 
Caco-2 cells that express hPEPT1. A brief fast or starvation (in rats) 
can upregulate PEPT1 expression with increased mRNA and protein 
levels (Ihara et al., 2000). Rats made diabetic by streptozotocin 
showed increased PEPT1 activity and increased protein levels most 
likely by enhanced stabilization of its mRNA(Gangopadhyay et al., 
2002). Furthermore, PEPT1 undergoes diurnal regulation in its 
activity and at the mRNA and protein expression level (Pan et al., 
2002).  
As PEPT1 transport activity also depends on the 
transmembrane proton gradient, which is mainly generated by the 
apical Na/H exchanger, any manoeuvres that alter pH gradients and 
membrane potential secondarily affect PEPT1 activity (Thwaites et 
al., 2002). In Caco-2 cells, PEPT1 expression is reduced by treatment 
with thyroid hormone (Ashida et al., 2002) whereas Ca2+ channel 
blockers, by decreasing intracellular calcium, increase PEPT1 activity 
acutely whereas elevating intracellular free calcium decreases the 
maximal transport activity (Wenzel et al., 2002).  
A very interesting adaptation is observed in patients with short 
bowel syndrome whose colonic epithelial cells express substantial 





human colon or present in only very low levels (Ziegler et al., 2002). 
An equally interesting adaptation is the existence of a Ca2+ and taste 
receptor-coordinated network that modulates the expression of 
peptide, glucose and excitatory amino acid transporters (Mace et al., 
2009).  
1.5.6 PepT1 in human pathophysiology 
An involvement of PEPT1 in inflammatory processes has been 
shown based on the finding that it is expressed in inflamed colonic 
tissues (Crohn's disease, chronic ulcerative colitis) and its capability to 
transport formyl-Met-Leu-Phe (fMLP), a known neutrophile attractant 
peptide derived from certain bacterial species (Dalmasso et al., 
2010;Ingersoll et al., 2012;Zucchelli et al., 2009). The functional 
coupling of PEPT1-mediated uptake of fMLP and increased 
neutrophile activation and migration suggests that PEPT1 – when it is 
expressed in colon – could amplify inflammatory processes. In 
addition, genetic polymorphisms in the Pept1 gene have been linked 
to inflammatory bowel disease (Zucchelli et al., 2009). 
1.5.7 PepT1 as a pharmacological target 
The capability of PEPT1 to transport a huge variety of 
compounds enables the rational design of pharmacological 
compounds that, in addition to their activity, possess good oral 
availability by delivery via PEPT1. This concept has yielded 
nucleoside-based antiviral drugs for various indications that, by 
coupling of the active core drug to an amino acid (mostly Val), 





PepT1. DOPA derivatives (DOPA-Phe) and Pro-Phe-esters of 
bisphosphonates have also been developed and shown to be 
transported by the peptide transporter (Ezra et al., 2000;Tamai et al., 
1998).  
Classic and well-characterized drug substrates of PEPT1 and 
PEPT2 are the numerous amino beta-lactam antibiotics of the 
cephalosporin and penicillin classes (Ganapathy et al., 1995), as well 
as selected angiotensin-converting enzyme inhibitors such as captopril 
and the ester prodrugs enalapril and fosinopril (Zhu et al., 2000). 
Their interaction with PEPT1 in the gut epithelium provides very good 
oral availability (generally between 40% and 90% of a dose) of these 
drugs. 
Other interesting drugs shown to be PEPT1-substrates include 
sulpiride, a selective dopamine D2 receptor antagonist (Watanabe et 
al., 2002), and the dipeptide-mimetic bestatin that, as a peptidase 
inhibitor also acts as an antitumor agent (Terada et al., 1997). The 
capability of peptide transporters for the uptake of delta-
aminolevulinic acid (ALA) can be also used for tumor therapy. ALA 
is a precursor of cellular porphyrin synthesis and was shown to be a 
good peptide transporter substrate (Doring et al., 1998;Neumann & 
Brandsch, 2003). When delivered to cells, efficient ALA uptake 
bypasses the normal tight control of endogenous ALA synthesis, 
leading to high level accumulation of porphyrins. Photodynamic 
therapy of tumors based on ALA administration uses laser-induced 
photoactivation of the accumulated porphyrins to submit tumor cells 





1.6 Electrophysiological characteristics of ion-
coupled transporters 
1.6.1 Electrical activities 
Overexpression of ion-coupled cotransporters in heterologous 
systems, especially Xenopus laevis oocytes, allows precise 
electrophysiological measurements which reveal detailed features in 
the kinetic mechanism. PepT1 as well as most cotransporters display 
two main kinds of electrical activity: in the absence of organic 
substrate, transient presteady-state currents (Ipre) are generated by 
charge relocation during voltage steps; in the presence of substrate, 
transport-associated currents (Itr) are recorded. 
1.6.2 Presteady-state currents and transport-associated 
currents 
Ipre has the characteristics of an intramembrane charge 
movement, as it is transient, saturable and symmetric (Bossi et al., 
1999b;Forlani et al., 2001;Mager et al., 1993b). Conversely, Itr is true 
transmembrane current, as the actual charge carriers physically move 
from the extracellular to the cytosolic compartment or vice versa. Ipre 
and Itr are reminiscent of two distinct currents in voltage-dependent 
ionic channels: the gating current and ionic current through the 
channel itself, respectively (Armstrong & Bezanilla, 1974;Hille, 
2001).  
In ionic channels, clearly distinct functions have been assigned 
to the two currents. The gating currents are believed to signal the 





permeation pathway (Catterall, 1993). The current through the channel 
can only occur when the gates are open, and therefore a simple 
relation, based on Ohm‘s law, exists between the probability of the 
channel being open and the current flux. Whereas the ionic current 
obviously depends on the presence of an electrochemical gradient for  
the permeating ion and this parameter does not affect the gating 
currents (Fesce et al., 2002b). 
In cotransporters the situation is certainly less clear; in fact, the 
charges responsible for Ipre cannot be clearly distinguished from those 
giving rise to the transmembrane current flux. Ipre of cotransporter 
may also be explained as due to rearrangement of a charged portion of 
the protein in the membrane field (Loo et al., 1998;Mager et al., 
1996b); however, the charge relocation might be due to the motion of 
ions that move back and forth between the external solution and an 
open vestibule in the transporter facing the extracellular side (Lester et 
al., 1996;Mager et al., 1996a).  
Whatever the actual mechanism, it is generally agreed that 
presteady-state currents represent a partial step in the transport cycle. 
The time integral of this kind of current represents the amount of 
charges that moves in the membrane electrical field in response to the 
voltage change. It is possible to note that the same amount of charges 
moves during the ―on‖ (from the holding potential, Vh, to a given 
potential) and the ―off‖ (when the voltage is returned to Vh) of the 
voltage pulse (Fig.6 B). Such behavior is reproduced by a simple 
electrical circuit constituted by a resistor and a capacitor in series 









Figure 1.6: A: electrical analog of rGAT1. The switch "GABA" is open in 
absence of GABA; therefore voltage jumps will displace a charge Q = CV 
on the capacitor plates, with rate r = 1/τ = 1/RC. Hence the product Q•r is 
equal to V/R, i.e., to the current flowing in the circuit when the switch is 
closed by the presence of GABA. B: time course of the relevant electrical 
quantities in response to a step voltage change across the membrane.  
Source: (Peres et al., 2004) 
 
1.6.3 Intramembrane charge movement 
The electrophysiological observations represent the starting 
point for the development of kinetic schemes of heterologously 





system is assumed: in state A the electrical charge associated with the 
transporter is located near the internal limit of the membrane electrical 
field, while in state B the charge is displaced toward the outer 
membrane margin (Fig.1.7). Clearly, the relative occupation of the 
two states will depend on the membrane potential: assuming a positive 
mobile charge, state A in Fig.1.7 will be populated at negative internal 
potentials, while at positive potentials the most populated state will be 
B. This description may be translated in terms of reaction kinetics 




Figure 1.7: Elementary representation of a two-state system explaining 
intramembrane charge movement. Source:(Peres et al., 2004) 
 
in which α and β are the voltage-dependent unidirectional rate 
constants (dimensions s-1) for the outward and inward charge 
movement, respectively.  
Consistent with the laws of electrodiffusion, α and β will depend on 
the membrane voltage according to the following general kind of 
expressions: 
α = kα exp(qδV / 2kT ) 





β = kβ exp(- qδV / 2kT ) 
Where q is the elementary charge, δ is the fraction of electrical field 
over which the charge movement occurs, k is Boltzmann‘s constant, T 
the absolute temperature and kα and kβ are the zero-voltage rate 
constants. Clearly, α will increase as the membrane potential is made 
more positive and β will increase as the membrane potential is made 
more negative. 
Considering a given population of molecules that can undergo 
reaction in Fig.1.7, constant, and defining the relative 
amounts of A and B as: 
     and              [eqs 1.3] 
we have: 
 
    [eqs 1.4] 
 
it is easy to verify that at equilibrium, B* is given by: 
             [eq.1.5] 
and therefore, replacing eqs 1.2 in eq.1.5:  
           [eq.1.6] 
which is a Boltzmann relation with slope s = qδ/kT , and in which the 
molecules are equidistributed in the two states at voltage   
/s. 
From eqs 1.4 it is also easy to derive the differential equation that 





                [eq.1.7] 
which may be solved to give: 
 (1-exp[-t/τ])               [eq.1.8] 
where the subscript 0 and ∞ respectively refer to the value before and 
after the voltage jump, so that  and  are the fractions of 
molecules in state B before and after the voltage change respectively; 
they may be obtained from eq.1.5 by using the corresponding values 
of α and β: 
 
             [eq 1.9] 
 
The time constant of the exponential (  is: 
          [eq.1.10] 
And therefore depends only on the final voltage but not on the starting 
voltage. 
Calling Qmax the total amount of electrical charge involved in the 
process, the time course of the transient current elicited by voltage 
changes can be obtained by differentiating eq.1.8 and multiplying the 
result by Qmax, which gives: 
             [eq.1.11] 
This expression constitutes the basis for the analysis of the presteady-
state currents observed in transporters. Fitting eq.1.11 to the 
experimental traces of transient current yields the time constant of 
decay, τ, while the time integral gives: 





which represents the amount of charge moved by the voltage jump. 
In particular, at any membrane voltage the quantity of charge 
displaced towards the inner side is given by 
. If, in agreement with standard notation, a minus sign is 
assigned to inward charge movement, this may be rewritten as: 
. 
The analysis of presteady-state currents is performed by first of 
all isolating these currents from the endogenous components of the 
oocytes membrane and from other contributions to the total current; 
this may be achieved by subtracting the traces recorded in conditions 
in which the presteady-state currents have been eliminated, by the use, 
for instance, of saturant concentration of substrate (Fig.1.8B), from 
the corresponding traces recorded in control conditions  (Fig.1.8A) 
(Bossi et al., 1999). A correction of the baseline may consequently be 
necessary before performing the integration of the transients 
(Fig.1.8C). The graph of the integrated charge against voltage shows 
the typical sigmoidal shape (Fig.1.8E) expected from eq.1.6. For each 
voltage step the ―on‖ and ―off‖ integrals coincide, as expected in a 
process in which the fraction of charge in the two positions at 
equilibrium conditions is determined only by voltage. 
The relaxation time constant τ may be obtained by fitting 
single exponentials to the isolated current records at each potential; a 
representative τ vs. V plot is shown in Fig.1.11D. The τ vs. V plot is 
bell-shaped, confirming the expectations of equations 1.2 and 1.10. 
Furthermore, the theory outlined above predicts that the maximum 





one position and 50% in the other and τ should depend only on the 
voltage after the jump. 
 
  
Figure 1.8: Analysis of presteady-state currents for the oligopeptide 
transporter rbPepT1. A: traces recorded in physiological solution, 
containing 98 mM Na
+
 among other ions; B: traces from the same oocyte 
after adding 3 mM Gly-Gln; C: isolated presteady-state currents resulting 
by the subtraction of the traces in B from those in A. D: relaxation time 
constant of the transient currents in C as function of voltage; E: charge vs. V 











































CHAPTER 2 MATERIALS AND METHODS 
2.1 Molecular Biology 
2.1.1 PepT1 cDNAs 
Complementary deoxyribonucleic acids (cDNAs) encoding 
PepT1 were cloned in pSPORT1 vector between SalI and NotI sites 
(for rbPepT1-FLAG cDNA) (Mertl et al., 2008) and between SalI and 
HindIII sites (for sb and zf PepT1 cDNAs). pSPORT1 (Figure 2.1) is 
an expression vector that presents ampicillin resistance (APr) and the 
reported multi cloning site (MCS). At both ends of the MCS there are 









Figure 2.1: pSPORT1 vector 
2.1.2 Construction of point mutations 
Mutations in rabbit PepT1 were obtained by site-directed 
mutagenesis (Quickchange Site-Directed Mutagenesis Kit, Stratagene 
Inc., Milano, Italy). Briefly, 20 ng of the plasmid containing the 
FLAG-wild-type PepT1 cDNA (Mertl et al., 2008) were amplified 
with 2.5 units of Pfu DNA polymerase in the presence of overlapping 
primers containing in their sequence the mutated codons: 
rbPepT1 D341R: 5′-cctggtccccatcatgcgcgccgtggtgtatcc-3′ 
rbPepT1 H57R: 5’-ggacgacaacctgtccacggtcgtctaccacacgttcgtc-3’ 
  




where the original sequence agg was transformed to xxx that 
corresponds to the following triplet: for R282D gat, for R282A gcg, 
for R282E gag, for R282K aag, for R282Q gac and for R282C tgt. 
Polymerase chain reaction (PCR) amplification was performed 
with 25 thermal cycles of 95°C for 30 s, 55°C for 1 min, and 68°C for 
14 min. Then, 10 units of DpnI were added directly to the 
amplification reaction, and the sample was incubated for 1 h at 37 °C 
to digest the parental, methylated DNA. JM109 super-competent cells 
were finally transformed with 1 μl of the reaction mixture and plated 
onto LB-ampicillin plates (see below for details). After plasmid 
purification, plasmid cDNAs were fully sequenced (Eurofin MWG 
Operon Biotech). 
2.1.3 Plasmid amplification, extraction and purification 
The vectors containing PepT1 cDNAs were introduced into 
JM109 strain of E. Coli by the means of the heat-shock procedure 
following the instructions of the bacteria supplier (Promega). 
Transformed bacteria were then left to grow for about 1 h in SOC 
medium. The medium contained : [(tryptone 2% (w/v), yeast extract 
0.5% (w/v), NaCl 10 mM, KCl 2.5 mM, glucose 20 mM)]. After, the 
cells were centrifuged, plated on plates containing medium (LB-Agar 
+ 50 µg/ml ampicillin) and incubated over night at 37°C.  
The day after, colonies were picked up and inoculated in liquid 
selective medium (LB added + 50 µg/ml ampicillin). Bacteria were 
left to grow over night at 37°C after which the plasmid DNA was 
extracted using Wizard® Plus SV Miniprep (Promega); following 
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supplier‘s instruction. The extracted DNA was loaded on a 1% 
agarose gel in TAE 1X buffer to check the quality and to estimate the 
concentration. 
2.1.4 In vitro transcription 
In order to achieve an efficient in vitro transcription, the clone 
containing the cDNA of interest has to be linearized in the 3‘ direction 
with respect to the coding region. The cDNA encoding rabbit PepT1-
FLAG transporters was linearized with NotI and the cDNA encoding 
seabass and zebrafish transporters with Hind III. 8-10 g of plasmid 
DNA were digested, then purified using the Wizard® SV Gel and PCR 
Clean-Up System (Promega) and eluted in 35 l of nuclease free 
water. 3 l were loaded on a 1% agarose gel in TAE 1X buffer to 
check the linearization. The remaining DNA was used for the in vitro 
transcription as detailed previously (Bossi et al., 2007).  
Briefly, the linearized DNA was incubated at 37°C for 3h in 
the presence of 200 units of T7 RNA polymerase, 18 μl of 5X 
Trascription Buffer, 8 μl of 100 mM DTT, 2.5 μl of RNasin 30 U/μl, 
13 μL NTPs mix (ATP, CTP, UTP 10 mM and GTP 0.5 mM), 6.5 μL 
of 10 mM Cap Analog (Promega), 10 μl RNA polymerase 20 U/μl 
(final volume 90 μL). After 10, 20, and 40 min from the beginning of 
the incubation, 1 μL of 25 mM GTP was added to the reaction. After 1 
h from the start of the transcription, a mix of 4 μl of 5X TB, 1 μl of 
100 mM DTT, 1 μl of RNasin 30 U/μl, 5 μl of NTPs mix, 1 μl of T7 
RNA polymerase 20 U/μl, 1 μl of 25 mM GTP, 4 μl of nuclease-free 
water was added to each sample. At the end of 3 h, the reaction was 
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stopped by adding nuclease-free water to a volume of 200 l. All 
enzymes were supplied by Promega Italia, Milan, Italy. 
The transcribed cRNA was extracted with 
phenol:chloroform:isoamyl alcohol, 25:24:1, pH 6.6, precipitated with 
LiCl 8M and washed with 70% EtOH. The dried cRNA was then 
resuspended in a small volume of nuclease-free water and the 
concentration estimated using a spectrophotometer (1 A260nm unit = 40 
μg/ml).Transcribed cRNAs had a modification which mimics an in 
vivo condition: the process of 5‘ capping. The so called ―Cap Analog‖ 
is a modified guanine (m7G(5')ppp(5')G) which, although is not 
necessary for the protein expression, increases the translation 
efficiency and also protects the mRNA from degradation. 
2.1.5 Heterologous expression in oocytes 
 Xenopus laevis oocytes are a powerful expression system 
(Fig.2.2) with numerous advantages: i) high expression rate of 
exogenous proteins (even after only 18 hours); ii) an efficient 
biosynthetic apparatus which allows all post-translational 
modifications necessary for the functionality and the correct targeting 
of the protein; iii) high density of proteins produced upon cytoplasmic 
mRNA injection; iv) dimensions well adapted for microinjection and 
voltage clamp; v) ease of maintaining in culture for quite a long period 
(ten or more days) with no particular sterile conditions; vi) co-
expression of different proteins in various combinations by simply co-
injecting the respective cRNAs; vii) low expression levels of 
endogenous membrane proteins (the endogenous channels have been 
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well characterized, thus it is easy to distinguish them from the injected 
proteins). 
 Xenopus oocytes however have some disadvantages: i) the 
expression of exogenous protein is transient; ii) the ideal temperature 
for their survival (about 18°C) is usually lower than the temperature 
appropriate for exogenous proteins (37°C for mammalian proteins) 
and this can affect the folding process; iii) although quiescent cells, 
oocytes possess their own genetic ensemble which might interfere 
with the exogenous proteins. 
 
Figure 2.2: Exogenous protein expression in Xenopus laevis oocytes  
Oocytes were prepared as described previously (Bossi et al., 
2007). They were obtained from adult female Xenopus laevis, the 
frogs were anaesthetised in MS222 (tricaine methansulfonate) 
0.10%(w/v) solution in tap water and portions of the ovary were 
removed through an incision on the abdomen. The oocytes were 
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treated with collagenase (Sigma Type IA), 1 mg/ml in ND96 Ca+ free, 
for at least 1 h at 18°C. After 24 hours at 18°C in modified Barth‘s 
saline solution (MBS), the healthy looking oocytes, were injected with 
12.5 ng of cRNA in 50 nl of water, using a manual microinjection 
system (Drummond). The oocytes were then incubated at 18°C for 3-4 
days in MBS before electrophysiological studies.  
The experiments were carried out according to the institutional 
and national ethical guidelines. 
2.2 Protein localization 
2.2.1 Single-oocyte chemiluminescence 
The expression of PepT1-FLAG isoforms at the oocyte plasma 
membrane was determined by the single oocyte chemiluminescence 
(SOC) technique (Zerangue et al., 1999),(McAlear et al., 2006;Rauh 
et al., 2010), that employs enzyme amplification with a 
chemiluminescent substrate and sensitive linear detection with a 
luminometer.   
Oocytes expressing different FLAG-PepT1 isoforms, as well as 
non-transfected oocytes, were washed twice for 5 min in ice-cold 
ND96 pH 7.6 and then fixed with 4% paraformaldehyde in ND96 for 
15 min at 4 ° C, rinsed 3x5 min with equal volumes of ND96, and 
then incubated for 1 hour in a 1% BSA-ND96 blocking solution (used 
in subsequent antibody incubation steps).  
Fixed and blocked oocytes were incubated for 1 h in primary 
mouse anti-FLAG M2 (Sigma, Milan Italy) monoclonal antibody (1 
μg/ml in 1% BSA-ND96), washed 6x3min in 1% BSA-ND96, 
incubated for 1 hour in secondary peroxidase-conjugated goat anti-
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mouse IgG 1 μg/ml, IgG-HRP (Jackson ImmunoResearch 
Laboratories), washed 6x3min in 1% BSA-ND96 and then 6x3min in 
ND96 alone.  
For chemiluminescence reading, each oocyte was transferred into 
a well of a 96 wells plate (Assay Plate White not treated flat bottom-
Corning Costar) filled with 50 μl SuperSignal Femto (Pierce); the 
washing solution was eliminated as much as possible. 
Chemiluminescence was quantified with a Tecan Infinity 200 
microplate reader. The plates were read not later than 5 minutes after 
the transfer of the first oocyte. The data were then acquired at least 
three times in 10 minutes and for each oocyte the mean of three 
readings was calculated. Results were normalized to the mean value of 
wild-type FLAG-PepT1 for each batch and are given in relative light 
units (RLU). 
2.2.2 Immunohistochemistry 
Oocytes in which transport activity had been confirmed 
electrophysiologically were fixed in 100% methanol at −20°C for 2 h, 
then rehydrated at room temperature (RT) for 15 minutes in 50:50 
(v/v) methanol/phosphate-buffered saline (PBS), followed by 2x15 
minutes washes in PBS. The fixed oocytes were then embedded in 
Polyfreeze tissue freezing medium (Polysciences, Eppelheim, 
Germany) and immediately frozen in liquid nitrogen. Cryosections (7 
µm) were obtained with a Leica CM 1850 cryostat. The sections were 
incubated in the blocking buffer [2% bovine serum albumin, BSA 
(w/v), 0.1% Tween in PBS] at RT for 30 min, then the primary 
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antibody, mouse anti-FLAG M2 (SIGMA, Milan Italy, 3.8 mg/mL) 
1:1000 in blocking buffer was added and incubated at RT for 1 h.  
Samples were washed 3x5 min in blocking buffer at RT. The 
oocyte sections were then incubated in the secondary antibody [CyTM 
3-conjugated AffiniPure Donkey Anti-Mouse (Jackson 
ImmunoResearch), 1.4 mg/mL, diluted to 1:1000 in blocking buffer] 
at RT for 45 min and again washed 3x5 min with blocking buffer. 
Images were observed with a fluorescence microscope Olympus BH2 
through a rhodamine filter set (excitation/emission filters 550/580nm). 
Images were acquired with a DS-5M-L1 Nikon digital camera system.  
2.3 Electrophysiology and data analysis 
 
 Membrane electrophysiology has several advantages over 
other techniques used in transport studies: i) the membrane voltage of 
the cell is under control, ii) the temporal resolution is high, iii) the 
results may be obtained immediately as data can be analyzed and 
interpreted in real-time, and consequently the protocols can be 
changed or adjusted during the same experimental session.  
These benefits may be exploited in the study of transporters; 
thereby adding valuable information and significantly increasing 
efficiency. The activity of electrogenic transporters, that translocate 
electrical charge, by definition, during their working cycle, is strongly 
influenced by the trans-membrane potential. Thus, tracer flux 
experiments suffer from some uncertainty, because the membrane 
voltage is not under control, and not only the value of the electrical 
gradient is unknown, but also bound to change as a consequence of 
the electrogenic activity of the transporter itself. A more reliable 
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evaluation of the activity of the transporter is obtained instead when 
the membrane potential is ―clamped‖.  
2.3.1 Two-Electrode Voltage-Clamp (TEVC) 
The ―voltage-clamp‖ technique was introduced by Marmont 
and Cole (Cole & Curtis, 1941), and by Hodgkin, Huxley and Katz 
(Hodgkin et al., 1952) to study the ionic currents underlying the action 
potential in nerve axons, and it has been extended to the study of 
transporters soon after the cloning and expression of the first 
transporters in Xenopus laevis oocytes (Hediger et al., 1987;Ikeda et 
al., 1989;Mager et al., 1993;Parent et al., 1992). 
The TEVC technique is based on the use of two 
microelectrodes, one for recording the transmembrane voltage and one 
for passing current (Figure.2.3). The recorded membrane voltage is 
compared to the desired (command) voltage and a compensating 
current is automatically injected into the cell by the appropriate 
electronic apparatus. In this technique the independent (controlled) 
variable is the membrane voltage, controlled by the experimenter, 










Figure.2.3 Two-Electrode Voltage-Clamp.FBA is the feedback amplifier, E’ 
is the voltage electrode and  I’ is the current electrode. 
 
When a current is generated due to the activity of the transport 
systems located in the membrane, a negative feedback in the circuitry 
injects into the oocyte a current that exactly compensates the charge 
flow through the cell membrane, in order to maintain trans-membrane 
voltage under control. In addition to keeping the membrane potential 
constant, membrane voltage changes of any desired form can be 
applied to the cell by the TEVC technique. In the case of ion-coupled 
transporters, the trans-membrane current is an indication of the 
transport activity, and the possibility of accurately controlling the 
membrane potential is particularly crucial in voltage-dependent 
processes. 
The ideal voltage clamp simply consists of a battery, a switch, 
a wire, the cell and an ammeter (Figure.2.4). Since the wire has zero 
resistance when the switch is closed, the membrane potential steps 
instantly to the battery voltage. This generates an impulse of current 
that charges the membrane capacitance (Q = CmVcmd), followed by a 
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steady-state current (Im = Vcmd/Rm) to sustain the voltage across the 
membrane resistance. 
 
Figure 2.4 The ideal Voltage Clamp 
In this work most of the experiments were conducted in 
voltage-clamp conditions, but some were also performed in current-
clamp conditions, i.e. without voltage control, but with the possibility 
of constant current injections. 
2.3.2 TEVC experimental setup 
 A schematic view of the TEVC experimental setup used in this 
work is shown in figure 2.5. 
  




Figure 2.5 Schematic representation of the experimental setup  
The voltage-clamp amplifier (GeneClamp, Axon Instruments 
Foster City, CA, USA or Oocyte Clamp OC-725B, Warner 
Instruments, Hamden, CT, USA) was connected to a computer 
through an AD/DA (analog-digital, digital-analog) converter 
(DigiData 1200, Axon Instr.). This device converts the analog signal 
from the amplifier to a digital signal intelligible for the computer, and 
vice versa. Usually, signals derived from the amplifier were also 
displayed on an oscilloscope (TDS 420, TekTronix Inc., Beaverton, 
OR, USA). 
A dissection microscope (Wild M3B, Leica Microsystems AG, 
Wetzlar, Germany) was used to visualize the oocyte, and 
micromanipulators (MM-33, Märtzhäuser Wetzlar GmbH & Co. KG, 
Wetzlar-Steindorf, Germany) were used to move the electrodes. A 
perfusion system consisting of a set (16) of syringes delivered the 
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various solutions to the unique solution inlet of the chamber (a 
modified version of RC-1Z, Warner Instr.). All the syringes were 
connected to the inlet by the use of two manifolds (MP-8, Warner 
Instr.) and were all positioned at the same height in order to have the 
same flow rate for each solution. Selection of the desired solution was 
performed by pinch solenoid valves (Sirai, Milan, Italy). 
The recording chamber has a small volume (about 200 l, 85 
ml/mm height) which allows a rapid solution exchange (about 8-10 
seconds in our system). The solution is aspirated by a modified 
aquarium pump through a suction reservoir connected to the oocyte 
well. The oocyte was placed in the chamber and impaled with the two 
microelectrodes. These intracellular glass microelectrodes were filled 
with KCl (3M) and had tip resistances between 0.5 – 4 MΩ. These 
resistance values were usually obtained by gently breaking the tips on 
the bottom of the chamber. Agar bridges (3% agar in 3M KCl) 
connected the bath electrodes to the experimental chamber. 
All the equipment needed for the recording (the dissection 
microscope, the perfusion system, the oocyte chamber, 
micromanipulators and reference electrode) are placed inside a 
Faraday cage, in order to reduce the noise derived from 
electromagnetic fields, and on an anti-vibration table. The cage and all 
the instrument inside it were electrically grounded. 
2.3.3 Protocols and data analysis 
In voltage-clamp mode the holding potential (Vh) was 
generally  -60 mV, unless otherwise indicated. The standard protocol 
consisted of 200 milliseconds (ms) long pulses to test potentials from -
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140 to +40 mV; in 20 mV increments. Other protocols including 
prepulses are described in the text. The current signal was filtered at 1 
kHz before sampling at 2 kHz. 
Two methods were used to isolate the presteady-state currents 
elicited by voltage jumps (Mertl et al., 2008;Sangaletti et al., 2009): in 
the first, the slow component of a double-exponential fitting of the 
transient was taken to represent the presteady-state currents, while in 
the second, the currents remaining after subtraction of the traces in the 
presence from those in the absence of substrate were assumed to 
represent the intramembrane charge movement.  
The isolated traces were fitted with single exponentials to 
obtain the time constant of decline, and integrated to calculate the 
amount of displaced charge, after zeroing any residual steady-state 
transport current. The presence of gently decaying currents during the 
voltage pulse was sometimes observed in some mutants at alkaline 
pH. In these cases, a sloping baseline was subtracted before fitting and 
integration. The two methods gave generally equivalent results; the 
subtraction method was preferred when the presteady state currents 
were fast, with time constants approaching that of the endogenous 
capacitive transients. 
The general procedures to analyse the electrophysiological 
data are summarized in figure 2.6. The voltage dependences of the 
decay time constant τ and the intramembrane charge movement Q are 
obtained from the isolated presteady-state currents.  
As expected, the equilibrium distribution of the charge moved 
during the presteady-state currents shown in figure 2.6 is sigmoidal 
and can be described with the Boltzmann equation: 
  


















Q ,     [eq.2.1] 
where Qmax is the maximal moveable charge; V0.5 is the voltage at 
which half of the charge is moved (that is, the midpoint of the 
sigmoidal Q/V curve); and σ = kT/q represents a slope factor, in 
which q is the elementary electronic charge, k is the Boltzmann 
constant, T is the absolute temperature, and  is the fraction of 
electrical field over which the charge movement occurs.  
The sigmoidal Q/V curve may represent the steady-state 
distribution of the transporter molecules between two conformations 
with the center of charge in two different locations of the membrane 
electrical field. The charge movement process may be described with 








where outrate and inrate are the unidirectional rate constants, and 
Qin and Qout are the amount of charge at an inner and outer position, 
respectively, in the membrane electrical field. It is easy to derive 

















where Qmax is the maximal moveable charge, obtained from the 
saturating values of the Q/V sigmoidal curve. From eq 2.2,  it is 
possible to derive (Fesce et al., 2002) the unidirectional rate constants 
of the charge movement and their voltage dependency, according to 
the relations: 
  



























      
 
 
Figure 2.6.General procedures used to determine the electrophysiological 
characteristics of ion-coupled cotransporters (the GABA transporter GAT1, 
in this case): in the upper row, the voltage dependence of the transport 
current (rightmost panel) is derived from the steady current levels elicited at 
various voltages by a saturating amount of substrate; in  the bottom row, 
exponential fitting of the isolated presteady-state currents gives the the 
-
voltage relationship is obtained from the integration of the transients (Q, 
right panel). 
 
Data were analyzed using Clampfit 8.2 (Axon Instruments), 
and figures were prepared with Origin 5.0 (Microcal Software Inc., 
Northampton, MA, USA). 
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2.4 Extracellular Solutions 
 
The oocyte culture and washing solutions had the following 
composition (in mM),  
1) ND96: NaCl 96, KCl 2,  MgCl2 1, CaCl2 1.8, Hepes 5, pH 7.6; 
2)MBS: NaCl 88, KCl 1, NaHCO3 2.4, Hepes 15, Ca(NO3)2 0.30, 
CaCl2 0.41, MgSO4 0.82, sodium penicillin 10 µg/ml, streptomycin 
sulphate 10 µg/ml, gentamycin sulphate 100 µg/ml, nystatin 10 U/ml, 
pH 7.6  
3) PBS: NaCl 138, KCl 2.7, Na2HPO4 8.1, KH2PO4 1.9, pH 7.6.  
4) The external control solution had the following composition (mM): 
NaCl, 98; MgCl2, 1; CaCl2, 1.8. 
Different pH buffers were used for the various pH values: for 
pH 6.5, Mes 5 mM was used; Hepes 5 mM was employed for pH 7.0 
and 7.5, while for pH 8.0 the buffer was Taps 5 mM. The final pH 
values were adjusted with HCl and NaOH. Substrates were added at 
the indicated concentrations to the appropriate solutions. 
The non-hydrolyzable substrate Gly-Sar was used for 
confirmatory intracellular injection experiments. A volume of 50 nl of 
a concentrated solution (200 mM Gly-Sar in pH 7.5 buffer) was 
injected; leading to an approximate final concentration of 20 mM 
(assuming an oocyte volume of about 500 nl). 
All substrates for electrophysiology experiments were 
procured from Sigma, Milan, Italy. Irbesartan was a gift from Sanofi-
Aventis. 
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Experiments were performed at room temperature (20–25 °C) 
except during the studies on the effects of temperature; where a range 





CHAPTER 3 RESULTS 
 
3.1 PRESTEADY-STATE CURRENTS 
The PepT1s of rabbit (rbPepT1), seabass (sbPepT1), and 
zebrafish (zfPepT1) exhibit presteady-state currents in the absence of 
organic substrate. Figure.3.1 compares the currents induced in each 
isoform by voltage pulses in the absence and presence of saturating 
Gly-Gln at pH 6.5. Although experiments have been performed in a 
more extended range (6.0–8.0), pH 6.5 seems to be close to the real 
physiological conditions, at least in rabbit PepT1 (based on the pH of 
the luminal surface of the mammalian small intestine) (Thwaites & 
Anderson, 2007). 
 
Figure 3.1 Comparison of PepT1 presteady-state currents from three 
species. In the absence of organic substrate (top row), all three transporters 
display slowly decaying transients in response to “on” and “off” voltage 
steps. The bottom row shows the steady currents induced in the same oocytes 
by the addition of 3 mM Gly-Gln and the simultaneous disappearance of the 
presteady-state currents. 
 














have already been described and analyzed (Nussberger et al., 
1997;Sangaletti et al., 2009), information on zfPepT1 is lacking. As 
shown in Fig.3.1 (top row), the two fish species, exhibited larger 
currents for hyperpolarizations than for depolarizations, while the 
transients from rbPepT1 are approximately symmetrical around   the 
-60 mV holding potential. Adding saturating amounts of organic 
substrate (3 mM Gly-Gln) elicited steady transport currents (Fig.3.1, 
bottom row) and, as commonly observed in most electrogenic 
transporters, abolished the presteady-state currents.  
The presteady-state currents were separated from the fast peaks 
due to the endogenous oocyte capacity, using two different procedures 
(see Materials and Methods for details). In the first, a double 
exponential function has been fitted to currents recorded in the 
absence of substrate. In the second, the current traces in the presence 
of saturating substrate have been subtracted from those in its absence 
and a single exponential fitted to the difference. In both cases, steady 
transport currents were subtracted before fitting the exponentials. 
As previously observed (Mertl et al., 2008;Sangaletti et al., 
2009), the two methods give virtually identical results. This is relevant 
not only to better understand the transporter mechanism, but is also 
important because of the intrinsic limitations of the two-exponential 
method. Namely, the separation of two exponentials by fitting is 
impossible when the two time constants are close in value. Because 
the time constants for charging the oocyte membrane capacity are 
generally around 1 ms, the two-exponential method becomes 
unreliable when the decay time constant of the presteady-state 





for both fish species at the most positive potentials explored (see 
below). In addition, both rabbit and seabass PepT1 exhibit an 
acceleration of the presteady-state current decay at alkaline pH 
(Nussberger et al., 1997;Sangaletti et al., 2009). For these reasons, the 
subtraction method has been used to isolate these currents.  
3.2 TRANSPORT CURRENTS 
The transport currents generated by rabbit, zebrafish, and 
seabass PepT1 have been previously studied (Kottra & Daniel, 
2001;Sangaletti et al., 2009;Steel et al., 1997;Verri et al., 2003). 
These three isoforms show a similar trend: in all cases, acidic external 
pH increases substrate affinity, but it either decreases (Kottra & 
Daniel, 2001;Verri et al., 2003) or does not affect (Sangaletti et al., 
2009;Steel et al., 1997) the maximal current. These features are 
illustrated in Fig.3.5 for the rabbit transporter; very similar curves can 
be observed for the zebrafish (Verri et al., 2003) and seabass isoforms 
(Sangaletti et al., 2009). In human PepT1, on the other hand, high 
acidity increases both substrate affinity and Imax (Fei et al., 1994; 






Figure.3.2 Transport-associated current from rabbit PepT1. Top row: I/V 
relationships of the transport-associated currents (substrate present minus 
substrate absent) at pH 7.5 (A) and 6.5 (B). Bottom row: values of Imax (C) 
and K05 (D) obtained by fitting the concentration-current relationships from 
(A and B) with the Michaelis-Menten equation. 
 
The decrease in Imax at acidic pH in rabbit and fish transporters is 
unexpected given that the inwardly directed proton electrochemical 
gradient increases. This effect, however, might be explained by a 
decreased cycling rate related to the slowing of the charge movement 
caused by protonation (see (Renna et al., 2011).  
A useful index of the overall transport efficiency (Figure 3.3) is 
given by the ratio Imax/K05, which is the slope of the Michaelis-Menten 
relationship at zero substrate concentration. The largest difference in 
efficiency, in favor of the more acidic solution in the physiological 
range of membrane potential, was observed in the rabbit transporter; 









































































































there was no significant difference in the zebrafish. This is in line with 
the acidic pH of the small intestine of rabbit but alkaline pH in 




Figur.3.3 Transport efficiency. Plots of the ratio of relative Imax/K05 for 
rabbit (A) seabass (B) and zebrafish (C). 
 
3.3 TEMPERATURE AND TRANSPORT KINETICS OF 
PepT1 
A close look at Figure 3.2 shows marked differences in the 
kinetic behaviour of the proteins. In particular, at the same 
temperature the two fish isoforms show similar rates of decline of the 
presteady-state currents, while in rabbit PepT1 they are much slower. 
Furthermore, the voltage dependence of the intramembrane charge 
movement and of the rate of decline in the fish isoforms are 
significantly shifted toward more negative potentials compared to the 
rabbit isoform.  
On the basis of these considerations, it may be hypothesized 
that the rabbit isoform of PepT1 exhibits slower kinetics at 22 – 24 °C 
compared to the fish isoforms because it is adapted to work at 


















































































temperatures around 37 °C, while the fish PepT1s may work optimally 
at this temperature. If the effect of increasing temperature on PepT1 is 
similar to those observed in GAT1 and SGLT1, i.e. an acceleration of 
the decay rate, accompanied by a shift towards more negative 
potentials of the presteady-state currents, then we may expect that the 
characteristics of rbPepT1 at its physiological temperature will 
approach those of sbPepT1 and zfPepT1 at lower temperature. 
Therefore, we examined the effects of temperature on PepT1 
functions. 
3.3.1 Temperature effects on rbPepT1 transport current 
Raising the temperature of the bathing solution from 20 to 30 
°C produces a strong increase in the transmembrane current generated 
by the activity of PepT1 exposed to 3 mM Gly-Gln. Sample records 
from the same oocyte are shown in Figure 3.4A. The traces are the 
recordings of the membrane current in response to a staircase voltage-
clamp protocol from -120 to +40 mV from Vh = -40 mV. Black color 
denotes the currents in the absence of substrate, while the red traces 
are the currents in the presence of 3 mM Gly-Gln. The presteady-state 
currents in response to each voltage jumps are visible in the black 
traces but not in the red ones (arrows).  
The average current-voltage relationships for the steady-state 
transport current from several oocytes tested at the three temperatures 
are plotted in Figure 3.4B, showing a large increase with higher 
temperatures. Figure 3.4C is an Arrhenius plot of the transport current 









AK actln  
 the slope of these lines corresponds to Eact/R where R is the gas 
constant, and Eact is the activation energy of the transition. 
Energies amounting to about 93 kJ/mol at -120 mV and to 72 
kJ/mol at -40 mV were found from this analysis. These values are 
close to those reported from other transporters (Hazama et al., 
1997;Hilgemann & Lu, 1999;Wadiche & Kavanaugh, 1998;Zeuthen 
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Figure 3.4.  Temperature effect on the transport current at pH 6.5. A: 
representative recordings of  the current before (black) and during (red) 
application of 3 mM Gly-Gln (GQ) in the same oocyte at the three indicated 
temperatures, and pH = 6.5. The voltage protocol consisted in a staircase of 
voltage steps from -120 to +40 mV in 20 mV increments, lasting each 200 
ms from a -40 mV holding potential. The arrows point to the presteady-state 
currents visible in the absence of substrate. B: Voltage-dependence of the 
transport current (substrate present minus substrate absent) at the indicated 
temperatures. Values are mean ± SE from 9 oocytes (2 batches). Data have 
been normalized to the current value at -120 mV and 20 °C for each oocyte 
before averaging). C: Arrhenius plot of the current as a function of 
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Fig. 3.5. Temperature effect on the transport current at pH 7.5. A: 
representative recordings of the current before (black) and during (red) 
application of 3 mM Gly-Gln (GQ) in the same oocyte at the three indicated 
temperatures. Same voltage protocol as in Fig. 3.4. Note the faster decline of 
the presteady-state currents compared to pH 6.5 (arrows). B: Voltage-
dependence of the transport current (substrate present minus substrate 
absent) at the indicated temperatures. Values are mean ± SE from 8 oocytes 
(2 batches). Data have been normalized to the current value at -120 mV and 
20 °C for each oocyte before averaging). C: Arrhenius plot of the current as 
a function of temperature at the different voltages. 
 
 
Similar results were found at pH 7.5 (Fig. 3.5). The activation 
energies calculated from the data of Fig. 3.5C were 123.0 and 82.3  
kJ/mol at -120 mV and  -40 mV, respectively. The reliability of the 
apparent increase of Eact at -120 mV at this pH, compared to the value 





transport current in these conditions (see Fig. 3.5A, rightmost panel, 
and (Renna et al., 2011).  
3.3.2 Temperature effects on rbPepT1 presteady-state 
currents 
The effect of temperature on the presteady-state currents (pss) 
of PepT1 was already visible in the recordings of Figure 3.4A that 
show a progressively faster decline of these transient currents as the 
temperature is increased. As mentioned above, this kind of effect was 
already reported in other ion-coupled cotransporters (Binda et al., 
2002) and reflects the acceleration in the rate constants of the 
intramembrane charge movement that underlies these currents. At pH 
7.5 the acceleration of the decline rate induced by temperature adds up 
to that caused by the alkaline pH itself (Bossi et al., 2011; Renna et 
al., 2011). This combined effect makes it difficult to perform  a 
reliable analysis of the presteady-state currents in these conditions, 
and for this reason we have limited this part of our study to pH 6.5. 
 Figure 3.6A shows sample recordings of the presteady-state 
currents in the same PepT1-expressing oocytes at four different 
temperatures. It can be seen that in addition to causing a faster decline, 
higher temperature produce a progressive shift of the transients 
towards more negative potentials. This kind of effect was already 
reported in two other transporters belonging to different families, i.e. 
SGLT1 (Hazama et al., 1997), and GAT1 (Binda et al., 2002). At the 
higher temperature tested (30 °C, Figure 3.6A), the combination of 





obtained in the Zebrafish isoform of PepT1 at 20 °C (Figure 3.6B and 
(Renna et al., 2011)). 
 
Figure 3.6. Effects of temperature on the presteady-state currents. A: 
representative recordings of the currents induced by voltage jumps from Vh 
= -40 mV (range-120 - +40 mV in 20 mV steps) in a rbPepT1-expressing 
oocyte at the indicated temperatures and pH = 6.5. B: recordings from an 
oocyte expressing the zebrafish isoform of PepT1 at 20 °C are shown for 
comparison. C: charge-voltage relationship obtained by integration of the 
transients after isolation of the presteady-state currents (open symbols: 
rbPepT1 at the three temperatures; solid squares. D: voltage dependence of 
the time constant of decline (same symbols as in C). Data from rbPepT1 are 
averages ± SE from eleven oocytes (two batches). 
 
A more complete analysis of presteady-state currents at 
different temperatures is presented in Figure 3.6C and D. The voltage 
dependence of the intramembrane charge movement, obtained by 
integration of the isolated presteady-state currents, is plotted in Figure 
3.6C for rbPepT1 (open symbols) as average curves after 
normalization to the maximal moveable charge (Qmax). The values of 















































the decline time constant are plotted in Figure 3.6D, quantitatively 
showing the acceleration produced by the higher temperatures. In both 
Qin-V and -V graphs, the leftward shift induced by higher 
temperatures is evident, and this suggests that a further increase in 
temperature (considering that the rabbit physiological temperature is 
38 – 39 °C) may bring both curves to approach those obtained in 
PepT1 isoforms from lower temperature-adapted animals, such as 
those for zebrafish, plotted as solid squares in Figs 3.6C and D. 
The voltage dependence of the unidirectional rate constants of 
the charge movement can be derived  from the experimentally 

























    (see eq. 2.3) 
Plots of these rates, calculated in this way for each individual oocyte 
before averaging, are presented in Figure 3.7A for the three tested 
temperatures, and they show that the two rates are differently 
increased by temperature: that is the outward rate is affected more 
strongly than the inward rate, and this fact explains the shift towards 




































































Figure 3.7. Temperature dependence of unidirectional rate constants. A: 
inward (solid symbols) and ouward (open symbols) rates obtained from the 
same oocytes of Fig. 3.6C and D. The effect of temperature is clearly 
stronger on the outward rate compared to the inward. B and C: Arrhenius 
plots for the outward and inward rate, respectively. All values are means ± 
SE 
The Arrhenius plots showing the weaker temperature 
dependence of the inward rate are presented in Figures 3.7B and C.  
The values of Eact were then calculated for each individual 
oocyte from a linear fit of the data such as in Fig. 3.7 and then 
averaged. The resulting values are plotted in Figure 3.8 as a function 
of voltage (open symbols). These graphs show that the activation 
energy for the outward charge movement is much larger than that 
involved in the inward charge movement. Furthermore, the filled 
symbols in Figure 3.8 represent the values of the activation energy 
derived from the Arrhenius plot shown in Figure 3.4C, that is, for the 





those calculated for the inward charge movement in the absence of 
organic substrate. The probability that these two sets of values are 
different is less than 20% at all voltages while, on the contrary, the 
difference between Eact for  the inward charge movement and for the 
entire cycle is highly significant at all voltages (P < 0.001 level, T test 
in both cases) 























Figure 3.8. Voltage dependence of the activation energies. Eact for the 
inward and outward charge movement in the absence of substrate, 
calculated from the data of Fig. 3B and C are shown with the open symbols 
as functions of membrane voltage. Filled squares are the activation energy 
derived from Fig. 3.4C, concerning the complete transport cycle. All values 
are means ± SE. All values for the full cycle are significantly different from 
those of the outward rate (P < 0.001, Student T test), while they are not 
significantly different from those of the inward rate. 
 
3.3.3 Affinity changes with temperature 
The effects of temperature on the rates of charge movement 





have then performed dose-response experiments at two fixed 
temperatures (20 and 30 °C) in the same oocytes, in order to 
determine the maximal transport current (Imax) and the apparent 
affinity in terms of the substrate concentration eliciting half of the 
maximal current (K0.5). The results, obtained using the same voltage 
protocol as in Fig.3.4 are illustrated in Fig. 3.9. The different shape of 
the I-V relationships at the two temperatures is shown in Fig. 3.9A 
and B, while the kinetic parameters, obtained after fitting a logistic 
equation to the data plotted as dose response curves, are shown in 
Fig.3.9C and D.  
The maximal current increases almost four times at 30 °C 
relative to 20 °C, confirming that the 3 mM substrate concentration 
used in the experiments of Fig.3.4 is close to saturation. The values of 
K0.5 are U-shaped, as already reported (Renna et al., 2011;Sala-
Rabanal et al., 2006). Interestingly, a shift of this curve toward more 
negative potential is observed at the higher temperature. This shift 
produces a statistically significant increase in the value of K0.5 (and 
therefore a decrease in apparent affinity) at 30 °C for membrane 
potential more positive than -60 mV, (P < 0.01, T test),  confirming 
the expectations. To assess the overall gain, or loss, of efficiency of 
the transport activity at the two temperatures, the ratio Imax/ K0.5 was 
calculated, and it is plotted in Fig. 3.9E. From these graphs a gain in 
efficiency is apparent at the higher temperature when the membrane 






Figure 3.9. Effect of temperature on the kinetic parameters of transport. A 
and B: voltage dependence of the transport current elicited by the indicated 
substrate concentrations at 20 and 30 °C, respectively. Data are means ± SE 
from 10 oocytes (two batches). C: plots of Imax obtained by fitting a logistic 
equation to the dose-response curves from the same oocytes as in A and B, 
normalized to the current at -120 mV and 20 °C in each oocyte before 
averaging. D: plots of the substrate concentration eliciting half of Imax 
obtained from the same fitting. E: plot of the Imax/K0.5 ratio from the data of 
panels C and D (arbitrary units). The K0.5 values at the two temperatures are 
significantly different (P < 0.01) from each other for voltages  -40 mV 
 
3.4 REVERSE MODE OF OPERATION IN PEPT1 
The question of reverse operation is a relevant issue in many 
cotransport systems, especially in the context of neurological 
disorders in which leakage of neurotransmitters into the extracellular 
space may have profound consequences. Although the physiological 
role of these transporters is reuptake, in several instances a release of 
neurotransmitter via the transporter has been reported. This reversed 

















































































































mode of operation may be either the effect or the cause of abnormal or 
pathological conditions. In the case of the glutamate transporters, 
export of glutamate may lead to the elevated extracellular levels that 
cause excitotoxicity (Rossi et al., 2000), while in the SLC6 family 
reversal of the operation of the dopamine transporter is caused by 
amphetamines (Khoshbouei et al., 2003;Seidel et al., 2005), and 
release of GABA through GAT1 has been hypothesized to concur in 
causing epileptic seizures (Richerson & Wu, 2003;Richerson & Wu, 
2004). 
To my knowledge, no indications of pathological conditions 
have been related to a reverse operation by PepT1, however this 
transporter is apparently capable of reverse transport especially when 
the external organic substrate concentration is low and the pH is 
alkaline (Kottra et al., 2009;Kottra & Daniel, 2001;Verri et al., 2003). 
Given the numerous functional and biophysical similarities among 
transporters belonging to different families, the study of the reverse 
transport in PepT1 was undertaken in order to compare its 
characteristics to those of the neurotransmitter transporters. 
Mutational studies of Pept1 have helped to established vital 
amino acid residues in its operation. For example, His 57 ((Fei et al., 
1997) and tyrosine residues around His 57 (Pieri et al., 2009) have all 
been shown to be important for the functioning of the transporter. In 
addition to these, arginine 282 and asp 341 have been reported to 
function as electrostatic gate in the transporter (Bossi et al., 2011).  
Previous reports from rabbit PepT1 (Meredith, 2004;Meredith, 





residues, arginine 282 and aspartate 341, may form a charge pair 
playing an important role in the transport function. The position of 
these two residues is shown in figure 3.10. 
 
Figure 3.10. Cartoon of PepT1 topology and helical distribution 
Representative traces from the various isoforms are shown in 
figure 3.11. All R282 mutants are able to generate pre-steady-state 
currents in the absence of substrate, as well as transport-associated 
currents with amplitudes comparable to the wild-type, while the 
currents observed in the D341R form were smaller, and neither 
transporter-related nor pre-steady-state currents could be observed in 
the double mutant R282D–D341R and in H57R (Bossi et al., 2011). 
Also it can be observed that there are slowly developing outward 







Figure 3.11. Current responses to voltage pulses from −140 to +20 mV 
(from Vh=−60 mV) in the absence and presence of substrate at pH 7.5 in the 
wild-type and indicated mutants of the rabbit PepT1 
Given this background, the following studies have been carried out 
both in the wild type and different arginine mutants of the transporter.  
3.4.1 Membrane expression of the FLAG protein 
Immunolocalization experiments were performed to 
understand whether the various mutants were correctly inserted in the 
oocyte membrane. Representative images are shown in Fig.3.12 A. 
The negative controls (non-injected oocytes and oocytes expressing a 
wild-type transporter with no FLAG), gave no visible signal in the 
membrane of the oocytes. All the other isoforms were correctly 
localized in the membrane to a variable extent. These observations 
were confirmed by the single-oocyte chemiluminescence (SOC) 
experiments that were performed on larger numbers of oocytes from 





the membrane at levels similar or greater than the wild-type, in 
agreement with previous results (Kulkarni et al., 2007). Our data also 
confirm the correct membrane localization of the non-functional 
mutant H57R (Uchiyama et al., 2003). However, the double mutant 
R282D-D341R gave only very weak signals in both the 







Figure 3.12. Surface expression of rbPept1wt and mutants. 
Immunohistochemistry (A) and chemiluminescence experiments (B) of 
oocytes expressing FLAG-rbPepT1 wt and the indicated mutants. 
These results are generally well correlated to the 





currents seen in the R282D-D341R double mutant is paralleled by the 
weak luminescence signal in Fig.3.12 for this isoform, while the large 
currents displayed by the R282 mutants are in agreement with the 
strong signals of the localization and luminescence experiments. On 
the contrary the small presteady-state and transport currents recorded 
in the H57R and D341R forms are in contrast with the large 
membrane expression seen in the results reported in Fig.3.12. Based 
on these observations, the reduced functionality of this last mutant 
appears to be attributable to a defect in the molecular mechanism 
rather than to insufficient targeting to the membrane. 
The presteady-state currents generated by the functional 
mutants maintained the sensitivity to external pH by showing a shift 
towards more negative potentials at more alkaline pH, as illustrated in 
Fig.3.13 for the R282D mutant. The isolated currents were analysed as 
explained in the Method, and the results of this analysis are plotted in 
the bottom row of Fig.3.13, showing the accelerating action of 
alkaline pH on the time constant and the shift towards more negative 
potentials induced by this pH on both τ/V and Q/V curves. Fitting a 
Boltzmann equation [eq.2.1] to the R282D data of Fig.3.13 gives V0.5= 
-45 ± 0.9 mV at pH 7.5, and 7.8 ± 6 mV at pH 6.5 in this group of 
oocytes.  
The estimated maximal moveable charge appears to remain 
substantially constant (41.4 ± 0.8 nC at pH 7.5 vs 37.6 ± 3.1 nC at pH 
6.5), although these data are subject to significant errors especially at 
pH 7.5 because of lack of saturation at positive potentials. The 
comparison with the wild-type data (filled symbols in Fig.3.13) shows 





shorter and that both τ/V and Q/V curves of the mutant are shifted 
towards more positive potentials (V0.5 = -59.2 ± 1.3 mV at pH 6.5 in 
this group). These effects were also seen, to various degrees, in all 
other arginine mutants. 
 
Figure3.13 Mutants in the charge-pair residues were pH-sensitive.Top row: 
traces of pre-steady-state currents isolated using the subtraction method in a 
representative oocyte expressing the rabbit R282D mutant at the two 
indicated pH values. Bottom row: values of the time constant of decay and of 
the amount of displaced charge at the two pH values. 
3.4.2 Outward currents in PepT1 
As mentioned above, outward transport currents have been 
observed in wild-type PepT1 when depolarizing pulses of relatively 
short duration (50–250 ms) are applied with the voltage-clamp 
technique from negative (−40, −60 mV) holding potentials (Kottra et 











































al., 2009;Kottra & Daniel, 2001;Verri et al., 2003). In the wild type 
PepT1, these outward currents are most easily seen at alkaline pH and 
relatively low substrate concentrations, since increasing the 
concentration of either substrate or H+ shifts the current-voltage 
relationships to more positive potentials, eventually bringing the 
reversal potential (Erev) of the transport current out of the experimental 
range (Verri et al., 2003).  
Interestingly, some mutants in arginine 282, that were 
previously shown to act as electrostatic gates in the transport 
mechanism  (Bossi et al., 2011)are capable of conducting quite large 
outward currents, as shown in Figure 3.14.  
The I/V relationships plotted in Figure 3.14b show that in the 
same conditions of pH and substrate concentration the value of E rev 
becomes progressively more negative as the positive charge of 
arginine is first neutralized to alanine and then changed in sign with 
aspartate. Moreover, the R282D mutant (but not R282A) generated 
significantly larger currents than the wild type. On the contrary, 
reverting the sign of the negative aspartate 341 to a positive arginine 
produces a transporter that is still functional but shows reduced 
transport currents and no reversal in the explored voltage range. In the 
group of oocytes illustrated in Figure 3.14, the average currents at 
−140 mV were: 568 ± 58 nA for wild type, 998 ± 172 nA for R282D, 
464 ± 94 nA for R282A, and 184 ± 35 for D341R (mean ± SE, n = 4–
7).  
Another evident feature in the traces of the transport currents 





during the voltage pulse (arrows in Figure 3.14a), a behavior that may 
suggest either the existence of a deactivating process or a progressive 
reduction in the driving force.  
Figure 3.14c shows estimates of the surface expression of the 
various isoforms, obtained with the SOC method. The level of 
membrane localization is in good correlation with the transport-
associated current in the case of the wild-type transporter and of the 
R282D and R282A mutants, but not for D341R, which, in spite of 
being highly expressed on the oocyte membrane, generates much 
smaller currents compared to the other isoforms. These observations 
suggest that the reduced functionality of D341R may be attributable to 
a malfunctioning in the molecular mechanism rather than to defective 










Figure 3.14   A Representative transport currents recorded in the wild-type 
and indicated mutants in the presence of 1 mM Gly-Gln at pH 8.0. Voltage 
pulses from −140 to +40 mV were applied from V h = −60 mV. The dotted 
lines indicate the zero-current level and the arrows the declining behavior of 
the currents. Note the amplified scale for the D341R mutant. B I/V 
relationships, averaged after normalization for each oocyte to the current at 
−140 mV (mean ± SE, n = 4–7 from two batches). C Surface expression, 
reported as results of the chemiluminescence experiments from oocytes 
expressing the wild-type and the indicated mutants of PepT1-FLAG. The 
chemiluminescence detected from 20 to 40 oocytes; from three different 
batches secondarily labeled with peroxidase-conjugated goat anti-mouse, 
IgG-HRP is shown. The data were normalized to the mean value of the wild-
type FLAG-PepT1 of each batch. 
In both R282D and R282A mutants, the reversal potential of 
the transport current is shifted by changes in either the proton 
concentration or the substrate concentration (Figure 3.14). This result 



















































































































































































































Fig. 3.15.  I/V curves showing the effects of changing pH and substrate 
concentration on the R282D and R282A mutants. A External alkalinization 
at fixed (1 mM) Gly-Gln concentration shifts the I/V curves towards more 
negative potentials. The change in E rev with pH is shown in B for R282D 
(filled squares) and for R282A (open squares; these symbols are used 
throughout). No significant changes in the slope conductance at E rev appear 
to be caused by alkalinization. C Positive shifts in the I/V curves produced 
by increasing the external Gly-Gln concentration at fixed pH (7.5) in the two 
mutants. The shifts in E rev induced in this case are plotted in D, together 
with the slope conductance at E rev; this parameter shows an increase at 
higher Gly-Gln concentrations. The current data were averaged after 
normalization for each oocyte to the current value at −140  mV and pH 7.5. 
Data points are mean ± SE (n = 4–5 from two batches). The slope 
conductance was calculated as the derivative of the relative I/V curve at E 
rev. The value of E rev for the R282A curve at pH 6.5 in A was linearly 
extrapolated. 
The shifts in E rev caused by the pH and substrate changes in 
the mutants R282D and R282A are plotted in Fig. 3.15 b and d. The 
slopes of the E rev versus pH curve are −42.3 and −43.7 mV/pH unit, 
respectively; although less than the 58 mV/pH unit predicted for a 





nevertheless consistent with a substantial contribution of H+ to the 
current. Similarly, the semilog plots of E rev versus [Gly-Gln] are not 
linear for both mutants (Fig. 3.15 d) with even lower slopes compared 
to the pH dependence.  
We also estimated the slope conductance (g slope) of the I/V 
curves at E rev. This parameter is plotted in Fig. 3.15 as a function of 
pH and substrate concentration for both mutants. Interestingly, while g 
slope increases with increasing concentrations of Gly-Gln (Fig. 3.15 d), 
it appears to be substantially independent from the proton 
concentration (Fig. 3.154b). This last result is contrary to the 
expectations for an electrodiffusive process, which would predict 
instead an increase in slope conductance when the concentration of the 
permeating species is raised (Hille, 2001). 
3.4.3 Current reversal in the wild type and R282 mutants 
The apparently anomalous effects mentioned above on the 
slope conductance around Erev, prompted us to perform other 
experiments aimed at better understanding this phenomenon, both in 
the wild-type and in the R282D/A mutants. The necessity of further 
controls was also suggested by the declining behaviour seen in the 
current traces in Fig.3.14. Long-lasting voltage- and current-clamp 
experiments have been performed on both wild-type and R282D 
mutant to investigate this point. Fig.3.16 A shows voltage-clamp 
experiments in which the membrane voltage was stepped twice from -
40 mV to +40 mV and back: the first step was given in the absence of 
substrate, and the second in presence of Gly-Gln 1 mM at pH 8. In 
















































Figure 3.16 A: Long lasting records showing the slow deactivation process 
following step voltage changes in R282D and WT PepT1: during the first 
seconds after the jump at +40 mV the current in the presence of substrate is 
more positive than in its absence (gray arrow); however, at later times it 
becomes more negative; B: Current clamp recordings at  pH 8 in R282D 
and WT PepT1: the addition of substrate induced depolarizations, implying 
that an inward current was generated by the transporter . 
Fig.3.16 Aa shows that jumping to +40 mV when the 
transporter is activated by 1 mM Gly-Gln causes an instantaneous 
large outward current (black arrow) that declines with time constants 
in the order of fractions of seconds, and it is not seen in absence of the 
substrate (grey arrow). Initially the current is more positive than the 
value recorded at the same voltage in absence of substrate (dashed 
line), but at the end of the 20 s period at +40 mV it becomes less 
positive (that is, a negative current after subtraction). A qualitatively 
similar behaviour, although with smaller currents, was observed in the 





Fig.3.16 B shows complementary experiments performed 
again on both wild-type and R282D with analogous results. The 
oocytes were kept in current-clamp conditions, i.e. an appropriate 
current was injected to keep the membrane voltage at a desired value 
before substrate application, but the membrane potential was left free 
to change as a consequence of transporter operation. The 
representative traces in Fig.3.16 Ba, from an oocyte expressing 
R282D, and in Fig.3.16 Bb, from an oocyte expressing wild-type 
PepT1, show that addition of 1 mM Gly-Gln at pH 8 (black bars) 
always induces a depolarization, irrespective of the starting value of 
the voltage (-40, 0 and +40 mV), indicating that using this 
experimental modality, the current generated by the transporter is in 
all cases in the inward direction. 
3.4.4 The outward current is due to temporary 
accumulation of substrates 
To discriminate whether the current decays seen in Figs 3.14 
and 3.16 were due to changes in electrochemical gradient or to a 
transporter-intrinsic deactivation process, a series of experiments 
employing different strategies was performed. Fig.3.17 illustrates the 
results of a representative experiment using a protocol in which three 
fast (200 ms) voltage ramps ranging from +40 to -100 mV (or from -
140 to +40 mV) were superimposed to a long lasting voltage step to 
+40 (or -140) mV in conditions inducing the decay of the transport 




























































Figure 3.17. Step and ramps protocols to investigate the basis of the 
transport current decline. Ab and Bb show the subtracted (substrate minus 
control) transport currents: both records show the slowly declining currents, 
which are in the outward direction in Ab and in the inward direction in Bb. 
Ac and Bc: I/V relationships; in Ac the reversal potential moves toward 
more positive values with the second and third ramp, whereas in Bc the 
opposite behavior is observed. I/V curves remain substantially parallel to 
each other. 
 
As shown in Fig.3.17. Ac and Bc, the I/V curves derived from 
the ramps shift along the voltage axis according to the application 
order and to the level of the long-lasting voltage pulse. The ramps 
superimposed to the depolarizing (+40 mV) pulse exhibit a 
progressive shift toward more positive potentials (Fig.3.17 Ac), while 
those applied during the pulse to -140 mV are moved with time 
toward more negative potentials (Fig.3.17 Bc). Interestingly, in both 





concluded that only the reversal potential is affected, not the 
conductance. 
These observations represent a strong indication that the 
decline of the transport current during either the depolarizing or the 
hyperpolarizing pulses is due to substrate concentration changes in the 
vicinity of the transporters. In fact, as a consequence of the results of 
Fig. 3.15, that indicate a coupled proton-substrate translocation, Erev 










   
where TC stands for transported complex. Considering this 
equation, the results shown in Fig. 3.17 may be explained if the 
continuous inward flow during the hyperpolarizing pulse will increase 
[TC]in (and/or decrease [TC]out) causing Erev to change with time to 
more negative values, as observed in Fig.3.17 Bc. On the contrary, the 
initial outward current seen when stepping the potential from –60 to 
+40 mV (Fig.3.17 Ab) will decrease [TC]in (and/or increase [TC]out) 
shifting Erev to more positive potentials (Fig.3.17 Ac). 
On the whole, the results shown in Fig.3.17 indicate that the 
outward current seen during short depolarizations is caused by a local 
accumulation of the transported complex at the intracellular side of the 
membrane and/or a local depletion of the complex at the extracellular 
side during the continuous inward transport occurring at the negative 
holding potential, confirming earlier suggestions (Kottra & Daniel, 
2001). 
In another series of experiments a prepulse lasting 2 s to +40 






the potential to variable 1 s long test pulses (+40 to -140 mV). 
Fig.3.18 shows this kind of protocol applied to an oocyte expressing 
the R282D mutant at pH 7.5. Upon addition of 3 mM Gly-Gln a 
slowly declining outward current is seen during the prepulse, while an 
opposite behaviour (i.e. a slowly declining inward current) is observed 
at the most negative test pulse potentials (Fig.3.187 A middle traces). 
Subtraction of  the currents in the absence from those in the presence 
of substrate gives the isolated transport currents (Fig.3.18) A 
rightmost traces), in which the declining behaviour at negative 
potentials during the test pulses is still visible. The average I/V 
relationship obtained from the currents values at the end of the test 
pulses is plotted in Fig.3.18 C (open squares). It can be seen that using 
this protocol no outward current can be observed up to +40 mV. In 
contrast, a clear current reversal around +10 mV is noticeable in the 
same conditions of pH and Gly-Gln concentration when using the 












































Figure 3.18.  Currents elicited by the prepulse protocol shown in B, in the 
absence  and in the presence  of 3 mM GlyGln at pH 7.5 in an oocyte 
expressing the R282D isoform; C: Plot of the current at the end of the test 
pulse in Ac (open symbols); for comparison, the filled symbols are the data 
obtained using the short-duration pulse protocol (from Vh -60 mV) from 
another oocyte in the same conditions. 
 
This experiment indicates that during the prepulse to +40 mV 
the accumulation/depletion effects are dissipated. To check the 
physiological relevance of this phenomenon, a similar approach was 
applied to oocytes expressing the wild-type form of PepT1. In this 
case a shorter (250 ms) prepulse to +40 mV was sufficient to abolish 
the temporary phase of outward current (Fig.3.19). The transport-
associated currents, obtained as usual by subtracting the traces in the 
absence from those in the presence of substrate, were always inwardly 
directed, even in conditions of alkaline pH and low organic substrate 





modest, allows an extension of the voltage range in which the values 
of apparent affinity (1/K05) and maximal current (Imax) can be obtained 
from a Michaelis-Menten analysis. 
 
































































Fig.3.19. Transport currents with the prepulse protocol.  In the wild-type 
PepT1 a 250 ms prepulse duration was sufficient to abolish any outward 
current elicited by the jump from the -60 mV holding potential to positive 
potentials. This is demonstrated by the fact that the subtracted currents (A, 
rightmost traces) are all in the inward direction; C, D: Imax and K05 obtained 
by Michaelis-Menten analysis on dose-current curves; open circles: same 
parameters calculated with the usual protocol. 
 
The average values of K05 and Imax calculated from a group of 
oocytes tested with such protocol at pH 7.5 is shown in Fig.3.19 C and 
D (open squares), together with their counterpart obtained using the 
customary pulse protocol in which the test pulses were applied 
directly from Vh = -60 mV without prepulse (open circles). It can be 





mV, because at more positive potentials the current at low substrate 
concentration becomes outwardly directed, the prepulse protocol 
allows an extension of the analysis up to +20 mV, although for K05 the 
statistical error becomes very large also in this case. 
3.4.5 Intra-cellular injection of substrates 
In order to find further support for the results reported above, a 
series of experiments has been performed by injecting substrates in the 
cytoplasm of the oocyte. This procedure was already reported to 
produce significant outward transport currents in wild-type PepT1, 
when using hydrolysis-resistant dipeptides, or inhibiting intracellular 
peptidases (Kottra et al., 2009). The results of our experiments on the 
wild-type and R282D, R282A and D341R isoforms are illustrated in 
Fig.3.20.  
In the upper part of this figure, membrane voltage recordings 
in current-clamp condition are shown: first of all it can be noted that 
in all isoforms the resting membrane potential becomes significantly 
more negative after substrate injection (range -75 to -100 mV), 
compared to the initial -20 to -50 mV. This progressive 
hyperpolarization, already observed in the wild-type (Kottra et al., 
2009), develops in few minutes after injection and it is not observed in 
oocytes not expressing the transporters. The development of a strongly 
negative resting potential is clearly consistent with the activation of an 
outward current by the transporter as a consequence of the increased 








































































































Figure3.20. Application of Irbesartan.Top row: current-clamp recordings 
showing the resting potential changes induced by application of Irbesartan 
(IS) and Gly-Sar.Bottom graphs: corresponding uncorrected I/V elationships 
before (open symbols) and after (filled symbols) the injection of Gly-Sar. 
Squares are data in the absence and circles in the presence of IS.  
 
Additional evidence is provided by the application of the 
blocker Irbesartan (IS) (Knütter et al., 2009): the traces in Fig.3.20 
show that while external Gly-Sar 3 mM depolarizes the membrane 
when applied either before or after the intracellular injection, the 
application of Irbesartan (2 mM) is effective in producing a 
depolarization only after substrate injection. These last observations 
indicate that, while the depolarizations induced by external Gly-Sar 
are due to the development of an inward transport current, those 
induced by Irbesartan are due to the inhibition of an outward current. 





and the Irbesartan-induced depolarization are seen in all isoforms, 
including D341R, in spite of the much lower currents generated by 
this mutant. The I/V curves in Fig.3.20 confirm then the findings 
reported in the preceding figures, by showing the presence of a strong 
outward current following the intracellular injection of Gly-Sar, and a 
reduction of this current by Irbesartan. 
3.4.6 Ion and substrate specificity 
Previous results (Kulkarni et al., 2007;Pieri et al., 2008) 
(Meredith, 2004) have suggested that residues R282 and D341 form 
an ion bridge whose cyclic breaking and formation may gate the 
translocation process. Furthermore, it has been proposed (Meredith, 
2009) that PepT1 may represent a transitional entity between 
transporters and channels. Then possible alterations in ion and 
substrate specificity in the R282D mutant have been investigated (the 
same results were obtained in R282A as well). The possible 
participation of other cations in the current elicited by the organic 
substrate was tested by replacing external Na+ with K+, Li+ or 
tetramethylammonium ion (TMA+). However these ionic substitutions 
did not significantly alter the shape of the I/V relationships in the 
presence of Gly-Gln at various concentrations and pH values, as 
shown in Fig.3.21 for pH 8 and Gly-Gln 1 mM. It can be seen that the 
reversal potential and the outwardly directed current are independent 





















































 in the external solution 
did not alter significantly the amplitude or the reversal potential of the 
transport current elicited by the organic substrate. 
 
This result, together with the observations of Fig.3.15 confirms 
therefore that the species carrying the electrical charge in both 
directions are indeed protons in complex with the organic substrate. 
The substrate selectivity of R282D was also compared with 
that of the wild-type with special attention to the ability to generate 
reverse current. A first series of results is exemplified in Fig.3.22, 
where the capacity to transport di-, tri-, tetrapeptides, as well as 
histidine by the R282D mutant was tested. It is known (Herrera-Ruiz 
& Knipp, 2003; Daniel et al., 2006) that PepT1 family members are 
able to transport several di- and tri-peptides, but not tetrapeptides. 
Furthermore, among the SLC15A family of transporters, the 
PepT subfamily is differentiated from the PHT subfamily by its 
inability to transport histidine. The representative records of Fig.3.22 
A show that, with respect to substrate selectivity, R282D behaves in a 
manner similar to the wild-type transporters. The same potency order 
was found in the other two tested mutants, R282A and D341R (not 





are also able to generate outward current when the short pulse 
























































Figure 3.22 Transport current elicited by di-, tri-, tetrapeptides and histidine 
in the wild-type and in the R282D mutant (GQ: gly-gln; GGGG: tetra 
glycine; GGG: tri glycine; LGG: leu-gly-gly; His: histidine). 
3.4.7 Charged dipeptides 
In the context of the substrate selectivity analysis, it seemed 
particularly interesting to examine the behaviour of the mutants in the 
charge-pair residues when charged dipeptides were used in place of 
the neutral substrates employed in all previous experiments. 
The relevance of introducing a negative or a positive amino 
acid in the substrate dipeptide, as well as its position was already 
studied in the wild-type PepT1 (Amasheh et al., 1997; Kottra et al., 
2002). An important conclusion from these studies was that the 
binding pocket of PepT1 can accept only neutral amino acids at the 
carboxyl terminus, while at the amino terminus all kinds of charges 





Fig.3.23 compares the transport currents generated at the same 
pH (7.5) and substrate concentration (1 mM) when a positive or a 
negative residue is introduced in either position of the dipeptide. The 
transport currents were normalized to the current generated by the 
neutral dipeptide Gly-Gln at -140 mV in each oocyte before 
averaging. The previous observations on the wild-type are 
qualitatively confirmed in the mutants: the transport currents 
generated by Lys-Gly are larger compared to Gly-Gln in all isoforms, 
while those produced by Gly-Lys and by the two negatively charged 
dipeptides are smaller. However, the degree of reduction or increase is 
different in the two mutants: in the R282D the differences are 
enhanced Lys-Gly showing a much larger increase (150% vs 60% in 
the wild type), while the currents generated by Gly-Lys, Gly-Asp and 
Asp-Gly are reduced relatively more than in the wild type. In the 
D341R form, that produces in general smaller currents (see Fig.3.14), 
the Gly-Lys, Gly-Asp and Asp-Gly currents are less strongly reduced, 
and the Lys-Gly current increases similarly to the wild-type.  
 
























































































Figure 3.23 Current-voltage relationships of the transport currents elicited 
by differently charged dipeptides in comparison with Gly-Gln (all at 1 mM) 






Furthermore, Lys-Gly can produce large outward currents in 
R282D, while all substrates produce strongly inward-rectifying 
currents in D341R. 
The results for the wild-type are in line with previous 
observations (Amasheh et al., 1997; Kottra et al., 2002), and 
qualitatively reflect the excess positive or negative charge of the 
different dipeptides at pH 7.5. The more than doubled slope of the I/V 
curves in the R282D mutant can be best explained with a nearly 
doubled charge/mole ratio and, in addition, with an increased turnover 
rate of the transporter. 
On the contrary, the lack of alterations in the substrate 
selectivity order suggests that these mutations do not interfere with the 
binding pocket of the transporter. This prediction has been tested by 
evaluating the amount of presteady-state charge movement removed 
by interaction with the various dipeptides. It is known that in many 
transporters, including PepT1 (Sala-Rabanal et al., 2006;Sangaletti et 
al., 2009) the presteady-state currents in absence of substrate are 
mutually exclusive with the transport currents (i.e, they are 
progressively reduced with corresponding increases in transport 
current). Fig. 3.24 shows the residual charge movement in presence of 
1 mM of different dipeptides (Gly-Gln, Lys-Gly and Gly-Asp) in 
representative oocytes expressing the wild-type and the mutants 































































Figure  3.24 Residual charge movement for the wild-type and the R282D 
and D341R mutants in the presence of a neutral, a basic and an acidic 
dipeptide as indicated (all at concentration 1 mM and pH 7.5). 
 
As shown in the traces of Fig. 3.23, 1 mM Gly-Gln and Lys-Gly 
remove almost completely the presteady-state currents in the wild 
type, while most of this kind of current remains in presence of the 
same amount of Gly-Asp (the same result was observed with Asp-Gly 
and Gly-Lys). These observations may be quantified comparing the 
Q/V curves obtained by integrating the presteady-state current isolated 
using a double exponential fitting of the traces in absence of substrate 
(considered to represent the total charge), to the integrals of the 
transient currents obtained by difference of the traces in absence and 
in presence of substrate (residual charge) (Fesce et al., 2002a). These 
data are shown in the bottom graphs of Fig. 3.24. Clearly the residual 





in the wild type, and for these substrates it remains a small fraction of 
the total charge in both mutants. In contrast, for Gly-Asp the residual 
charge is close to the total charge in all isoforms. Analogous results 
were obtained for the other, poorly functional dipeptides (not shown). 
The amount of residual charge can be considered an estimate 
of the fraction of transporters not involved in the actual transport, i.e. 
transporters that do not interact with the substrate. In this view, the 
data of Fig. 3.24 indicate that for all isoforms Gly-Asp interacts 
poorly, while Gly-Gln and Lys-Gly show a comparable degree of 
interaction between each other, although in the mutants this level 
appears lower than in the wild type. 
Taking together the results of Figs 3.23 and 3.24, it can be 
concluded that, since the level of interaction of Gly-Gln and Lys-Gly 
with the R282D mutant is similar, the more than twofold increase in 
transport current by Lys-Gly should be ascribed to the increased 
charge/mole ratio of the transported complex, and possibly to an 
increased turnover rate. 
3.5 TRANSPORT EFFICIENCY OF DIFFERENT 
DIPEPTIDES ACROSS SPECIES 
The need to optimize dietary nutrients in small animals has 
given rise to trials of different feed combinations in animal husbandry. 
This is perhaps strongest in aquaculture where optimized protein 
absorption is important for increased fish size, muscle mass and 
overall health. While commercial gain is a motivation, there is also a 
scientific angle to the feed combinations with respect to PepT1; as the 





properties of the transporter, while at the same time giving an 
evidence-based feed formulation to aquaculturists. 
The use of alternative protein sources in fish meal causes a 
reduction of fish growth and feed utilization efficiency and an increase 
of diseases. Plant protein sources are used to replace fish meal in feed 
formulations, but are inferior in their essential amino acid (EAA) 
composition. With increasing use of plant protein sources in fish 
feeds, EAA supplementation becomes necessary. 
Available data show that common carp larvae (agastric fish) 
diets based on free amino acids and synthetic dipeptides are not 
appropriate (Zhang et al., 2006); while trout (gastric fish) fed a 
formulated casein–gelatin diet supplemented with synthetic peptides 
show a growth rate similar to those fed a protein-based formulated 
diet or commercial feed (Terjesen et al., 2006). Similar to trout, 
agastric silver bream (Vimba vimba) larvae and juveniles accepted, 
digested and absorbed dipeptide and casein-based diets containing 
50% protein (Ostaszewska et al., 2008). Their survival and growth 
rate was similar to fish fed casein–gelatin (protein) based diets. Also, 
histological examination of the digestive tract of silver bream fed 
dipeptides and casein-based diets containing 50% protein showed no 
nutritional deficiencies (Ostaszewska et al., 2008). 
The results of a recent study (Ostaszewska et al., 2010) proved 
that rainbow trout (Oncorhynchus mykiss) fed a formulated Lysine–
Glycine dipeptide supplemented diet — PP, free lysine and glycine 
supplemented diet — AA and commercial starter (Aller Futura — AF) 
showed a significantly higher growth compared to fish fed control diet 





expression of PepT1 oligopeptide transporter was also observed in the 
intestine of fish fed with formulated diets as compared to the fish fed 
commercial starter AF. 
Moreover, most of the studies in this area have been based on 
in vivo absorption models. This is understandable. However, given the 
many advantages of electrophysiology previously reviewed, and the 
fact that peptide absorption is predominantly carried out by PepT1 in a 
proton dependent process, it is possible to study the transport kinetics 
and interactions of many peptides with the transporter using an 
electrophysiological approach. 
3.5.1 Species-specific Preferential transport of 
dipeptides 
Species-specific differences were observed in the potency 
order among the various substrates (tested at 1 mM) (Fig 3.25), and in 
the voltage-dependence of the current amplitude (Fig 3.25). 
Particularly Lys-Met was the best substrate at all tested potentials in 
seabass PepT1, as well as in the rabbit transporter, while in the 
zebrafish isoform all tested dipeptides (except Gly-Lys) elicited 
similar currents independently of the charge position or amino acid 
composition. KK and KKK are already known not to elicit 







Figure 3.25. A record showing the transport current generated by each 
substrate (3mM) at pH 7.5. In rbPepT1 and zfPepT1, the dipeptide lysine-
methionine gives the highest transport current which becomes less when the 
position of the lysine is changed in methionine-lysine (MK).The zfPepT1 












































Figure 3.26. I/V curves showing transport current generated by the different 
dipeptides. From a holding potential of -60, current generated is recorded at 
different membrane voltages (-60 to +40) In sb and rb PepT1s, KM 
transport gives the highest current while KK and KKK are only modestly 
transported. However in zfpepT1, KK gives high transport current at more 
negative potentials. 
3.5.2 Effects of extracellular pH 
In all isoforms the substrate potency order was pH-independent 
in the range 6.5 -7.5 (Fig.3.27), and the tripeptide Lys-Lys-Lys did not 
give rise to any current. In rabbit and seabass PepT1s the dipeptide 
Lys-Lys was only modestly transported at all voltages, while in the 
zebrafish a strong current increase was observed at negative 
membrane potentials. 



































































































































Figure 3.27. I/V curves showing transport current generated by the different 
dipeptides at two different pH values in the sb and zf PepT1s. In both 
isoforms, there is no significant effect of changing the pH on the transport 
current generated, however the high transport current of KK in zfPepT1 is 





3.5.3 Transport efficiency 
The dose response curves were determined at different 
voltages from -140 to -20 mV and the ratio of the relative Imax/K0.5 
was calculated. In the seabass and rabbit PepT1 these parameters 
show the importance of the position of lysine in the dipeptide (Figure 
3.28a). These proteins have very low affinity for Lys-Lys and Gly-Lys 
that highly reduce the transport efficiency; the other dipeptides tested 
were quite similar in affinity (between 0.2-0.8 mM) with small 
changes with voltage, but the transport efficiency was significantly 
higher for Lys-Met and Lys-Gly. In zfPepT1 relatively high affinity 
and excellent transport efficiency were shown by Met-Lys and Lys-
Met, while low efficiency was found for Gly-Lys (Figure 3.28b).  
































































Figure 3.28a. Imax, affinity and transport efficiency (TE) plots in the 
sbPepT1. Here again, having lysine in the first position is more efficient for 
the transporter while the least transported substrate has very low efficiency 
of transport. Although GQ and GK have very high affinities, this does not 






































































Figure 3.28b Imax, affinity and transport efficiency (TE) plots in the zebra 
fish. Compared to what was obtained in the rabbit and seabass isoforms, the 
tested dipeptides did not show wide variations in the maximum currents 















CHAPTER 4 DISCUSSION 
 
4.1 Comparison of the presteady-state currents in 
the different species 
An analysis of the presteady-state currents with respect to the 
voltage dependence of the decay time constant and the amount of 
displaced charge showed that they are positioned differently (at the 
same external pH) on the voltage axis. The rabbit curves are positively 
shifted compared to the zebrafish curves are negatively shifted; with 
the seabass curves located close to those of the zebrafish.  
In addition, the decline in the presteady-state current following 
voltage jumps is faster in the zebrafish and seabass transporters than 
in the rabbit isoform. These results are in good agreement with the 
different isoelectric points of the three proteins: 7.47, 6.68, and 6.00 
for rabbit, seabass, and zebrafish, respectively ((Daniel et al., 2006) 
and our calculation). This suggests that rabbit PepT1 may be 
protonated more easily than the fish isoforms.  
4.2 Temperature and PepT1 
In contrast to the numerous advantages offered by the method of 
expressing heterologous proteins in Xenopus laevis oocytes, this 
approach has the disadvantage of working with oocytes which do not 
tolerate the temperature levels that are physiological for mammals. 
This limitation prevents a full knowledge of the properties of the 
protein under study in its ideal physiological condition. Commonly, 
oocyte studies are performed at room temperature (22 ± 2 °C) in our 





characteristics of the species.  
4.2.1 Comparison with poikilotherm PepT1s and 
structural implications 
In a recent work (Renna et al., 2011), we compared the 
electrophysiological properties of three PepT1 isoforms from different 
species (rabbit, zebrafish and seabass). At room temperature, the two 
fish isoforms behaved similarly in terms of kinetic parameters of 
transport, while the rabbit isoform showed markedly slower kinetics. 
In addition, the parameters that characterize the presteady-state 
currents, i.e. the QinV and τ/V curves were shifted to more negative 
potentials in both fish PepT1s compared to the rabbit isoform.  
This result confirms that orthologous proteins from differently 
temperature-adapted species tested at the same temperature show 
variation in functionality, aimed at the compensation of the kinetic 
properties.  
Clearly, the present kind of approach neglects possible 
differences in the lipid composition of the native membranes of each 
transporter isoform.  These in turn may possess different fluidity 
properties that will influence the behaviour of the proteins. When 
expressed in the Xenopus oocyte membrane, the different transporters 
are studied in the same molecular environment, and consequently, the 
description of their properties in these conditions may not entirely 
reflect their behaviour in the real physiological situation.. 
Anyway, these results show that at higher temperature the 
properties of the rabbit PepT1 approach those of the fish species; 





species when the transporters operate at their physiological conditions. 
Furthermore, this observation implies that structural differences 
should exist between the mammal and fish isoforms that would confer 
enhanced flexibility in the latter at lower temperature (Fields & 
Houseman, 2004). 
4.2.2 Activation energies 
The negative shift of the Qin/V and τ/V curves observed in 
rbPepT1 at higher temperatures confirms analogous observations 
obtained for GAT1 and for SGLT1 (Binda et al., 2002;Hazama et al., 
1997). This effect appears therefore to be of general relevance in the 
operation of cotransporters; since these three proteins belong to three 
different gene families, namely SLC15A1 (PepT1), SLC6A1 (GAT1) 
and SLC5A1 (SGLT1).  
Derivation of the unidirectional rate constants for the 
intramembrane charge movement measured in the absence of organic 
substrate shows that the shift is caused by a stronger effect of 
temperature on the outward rate compared to the inward rate. 
Consequently, analysis of the Arrhenius plots of the unidirectional 
rates indicates that the transitions involving the inward and outward 
movement of electric charge in the membrane electrical field possess 
different activation energies, and particularly the Eact for the outward 
movement is two to three-folds larger than that for the inward 
movement. This result is consistent with the general observation that 
the apparent substrate affinity for reverse operation is for most 
transporters much lower than that for forward transport (Cammack et 






As shown in Fig. 3.8, the height of the energy barrier for the 
inward charge movement appears to increase at negative potentials. 
This result is puzzling because an opposite behaviour would be 
qualitatively expected (since the barrier will be decreased when the 
internal potential is made more negative), while for the outward 
transition the opposite effect could be presumed. Furthermore, the 
contribution of the electrical field across the cell membrane should be 
much smaller, as only 9.65 kJ/mole is needed for a 100 mV voltage 
change. This point will require further investigations.  
Interestingly, the activation energy for the complete cycle, i.e. 
when the organic substrate is present, is the same as that for the 
inward charge movement in the absence of substrate (Fig. 3.8). This 
finding indicates that during the forward transport cycle, which is the 
physiological working condition, the main energy barrier to be 
overcome is the charge-moving initial step, while the other steps 
needed to complete the cycle will require only minor energy 
contributions. 
The effects of temperature on the transport current are similar 
at the two tested pH (6.5 and 7.5). In both conditions the activation 
energy for the complete cycle is around 80 kJ/mole at the expected 
physiological membrane potentials (-40 - -60 mV). The high Q10 (> 5) 
observed at very negative potentials at pH 7.5 (Fig. 3.5C) is probably 
not very reliable, since at these potentials the transport current shows a 






4.2.3 Apparent substrate affinity 
The results presented in Fig. 3.9, show a shift in the K0.5-V 
relation when the temperature is increased. This shift goes in parallel 
with those observed for the Qin-V and τ-V curves illustrated in Fig. 3.6 
and gives support to the notion of an inverse causal correlation 
between the speed of the charge-moving transitions and the substrate 
affinity. Indeed such correlation has already been observed in PepT1 
when the pH of the external solution is changed (Renna et al., 2011), 
and more generally in other transporters; following conditions that 
affect the unidirectional rates of charge movement (Giovannardi et al., 
2003;Soragna et al., 2005). 
This causal link can be understood considering that in PepT1, 
as well as in several other transporters, the charge-moving transitions 
occurring before substrate binding, represent the limiting step of the 
turnover rate (Nussberger et al., 1997;Renna et al., 2011;Sala-Rabanal 
et al., 2006)) . Consequently, the lifetime of the conformational state 
in which substrate binding can occur will be shortened when the 
charge equilibration rate is increased (e.g. in the present case, by a 
higher temperature).  
Interestingly, a significant decrease in affinity at lower 
temperature was reported in the Drosophila serotonin transporter 
(Beckman & Quick, 2001), and results pointing in the same direction 
may also be found in an earlier paper on the noradrenaline transporter 
(De Oliveira et al., 1989). It must be underlined however that 
temperature may also affect the flexibility/stability balance of the 
binding site structure, contributing to altering the substrate affinity 





The lower affinity at higher temperature will in principle 
counterbalance the increased Imax in terms of overall transport 
efficacy. However, as shown in Fig. 3.9E, in the physiological range 
of membrane potentials the increase in Imax prevails over the affinity 
decrease, confirming a clear gain in efficiency at higher temperatures 
that could even be more significant at the body temperature of the 
animal. 
In summary, the observed effects of temperature on the 
electrophysiological properties of the rabbit PepT1 show that they 
become qualitatively and quantitatively similar to their fish 
counterpart when both are examined at their physiological body 
temperature. Furthermore, the detailed analysis of the biophysical 
parameters reveals interesting correlations between the 
thermodynamics requirements of the different transitions in the 
transport cycle, as well as a significant decrease in the apparent 
substrate affinity at higher temperatures. Since this effect appears to 
be a direct result of the accelerated turnover rate, it is expected to be a 
common feature of ion-coupled cotransporters (Beckman & Quick, 
2001), and it may be expected to occur for other transporters, with 
relevant consequences on their physiological functioning.  
4.3 Reverse operation in PepT1 
The PepT1 mutants investigated in the present work are 
correctly expressed in the oocyte membrane (Fig.3.12), and maintain 
the characteristics of true cotransporters, as it is shown by the fact that 
both protons and substrate concentrations affect the reversal potential 
of the transport current (Fig.3.15), and that the substrate selectivity is 





the shifts in Erev significantly deviate from the predictions of the 
Nernst equation. Further difficulties arise when examining the slope 
conductance of the transport current at the reversal potential: 
according to the theory of electrodiffusion (Hille, 2001), and 
intuitively as well, this parameter should increase when the 
concentration of the diffusing species is increased. As shown in 
Fig.3.15, this is verified for the dipeptide substrate Gly-Gln, but not 
for protons, for which no significant dependency of gslope is found.  
Having established that R282D and R282A can be considered 
as true cotransporters with some interestingly altered properties 
(conspicuous outward currents), the functional and structural 
determinants of reverse operation in these proteins have been 
investigated. 
4.3.1 Determinants of reverse operation in PepT1 
The experiments illustrated in Fig.3.16 show that the outward 
currents visible in Figs 3.14 and 3.15 are only temporary and may be 
consequent upon the active state of the transporters at negative 
holding potentials. These declining outward currents might be 
considered similar to the ―tail‖ currents observed in voltage-activated 
ionic channels when stepping the voltage from a condition in which 
the channel is open, to other voltages where it will close (Hille, 
2001;Hodgkin & Huxley, 1952). If this is the case, the I/V curves 
obtained from relatively short (<1 s) pulses may actually represent 
―instantaneous‖ I/V relationships of the current generated by the 





The observation (Figs 3.13 and 3.17) that the transport current 
declines during strong voltage pulses not only in the depolarizing but 
also in the hyperpolarizing directions further suggests that this effect 
may arise from changes in the driving force, rather than from an 
intrinsic deactivation process of the transporter, because this last kind 
of process usually depends monotonically on voltage. The hypothesis 
of a reduction in driving force is demonstrated by the results of the 
experiments of Figs 3.17, 3.18 and 3.19, as well as from the long-
lasting recordings of Fig.3.16. In fact, during a prolonged flux of the 
proton-substrate complex, a local accumulation and/or depletion of the 
complex may occur in the vicinity of the transporter, and this will 
decrease the concentration-dependent component of the 
electrochemical gradient causing a current decline. 
The experiment of Fig.3.17 clearly demonstrates the 
occurrence of this phenomenon in both directions: in fact, during a 
long lasting hyperpolarization the reversal potential becomes 
progressively more negative in agreement with a decrease in the out/in 
ratio of the concentrations of the transported species [eq.3.9]. Vice 
versa, during a long lasting depolarization, the Erev shift is toward 
more positive potentials; consistent with an increase in the out/in  
concentration ratio. However the I/V relationships measured at 
different times during the long pulses in either direction remain 
parallel to each other, excluding changes in the intrinsic rate of 
transport.  
Although this effect is most evident in the two arginine 282 
mutants, it was shown that the hypothesis of a transport-dependent 





wild-type transporter (Kottra & Daniel, 2001). The experiments of 
Figs 3.18 and 3.19 show that using an appropriate protocol the 
accumulation/depletion effect can be eliminated, and this leads to 
more accurate determinations of the kinetic properties of transport 
(Imax and K05), whose values can be obtained over an extended range 
of membrane potentials.  
The ability to conduct current in the outward direction has 
already been demonstrated in the wild-type PepT1 (Kottra et al., 
2009). The results in the present work show that not only mutants in 
arginine 282 but also D341R exhibit the same capacity in the presence 
of high intracellular concentrations of a non-hydrolyzable substrate. 
This finding indicates that the different shapes of the I/V curves 
exhibited by the different isoforms (i.e. inward rectifying vs linear, see 
Figs 3.14 and 3.23), obtained using a classical pulse protocol from Vh 
= - 60 mV is not related to an intrinsic incapacity of the wild-type and 
D341R forms to transport in reverse mode, but depends on the 
different transport rates, producing different degrees of 
accumulation/depletion effects. Indeed the transformation from linear 
to inward rectifying can be obtained using appropriate protocols (see 
Fig.3.19). 
4.3.2 Other substrates 
Of the two residues forming a putative charge-pair in the 
PepT1 structure, R282 and D341 (Bossi et al., 2011;Kulkarni et al., 
2007;Pieri et al., 2008), only mutants in arginine 282 present the 
outward current phenotype (Fig.3.14). Our initial results using the 





the substrate flow both in terms of amplitude and direction, since the 
I/V relationships are approximately linear; while the symmetric 
mutation D341R has an opposite action, rendering more difficult the 
transport of substrates, and enhancing the inward rectification 
property already present in the wild-type. 
The subsequent experiments in the presence of different 
cations (Li+, K+ and TMA+), and using various organic substrates, 
showed that the mutations do not introduce qualitative alteration in 
ionic selectivity, nor in substrate specificity. Protons appear to remain 
the charge carriers, and the potency order of substrates of different 
size or bearing different charge is not changed compared to the wild-
type. Furthermore, the reversal of the transport current can also be 
observed with tripeptides, suggesting that this property is not 
substrate-dependent, but is intrinsic in the mutated transporter. 
The selectivity order of the charged dipeptides remains 
substantially unaltered in the mutants compared to the wild-type at pH 
7.5. The two negatively charged dipeptides produce only small 
currents, reflecting the high percentage of the side chains bearing a 
negative charge at this pH. The two positive dipeptides highlight the 
relevance of the position of the charge: when the lysine is at the amino 
terminus the transporter is able to generate larger currents, while when 
it is located at the carboxyl terminus the currents are much reduced 
(Kottra et al., 2002).  
Quantitatively, the behaviour of the charge-reverting mutants 
R282D and D341R is opposite in many respects: while R282D shows 
increased current relative to the wild-type, the current generated by 





with the idea of these two residues being part of the gate controlling 
the flux of inward positive charges: neutralization of the positive 
arginine 282, or its replacement with a negative amino acid, may 
facilitate the approach of the positively charged transport complex, 
while the replacement of the negative aspartate 341 with a positive 
arginine may have the opposite effect.  
This notion is also supported by the amplified increase 
(relative to Gly-Gln) in the current generated by Lys-Gly in the 
R282D mutant compared to wild-type and D341R. This effect is 
mirrored by the stronger reduction in the same mutant of the current 
generated by Asp-Gly, compared to the wild-type. Interestingly, this 
last substrate produces a higher fraction of the Gly-Gln current in the 
D341R mutant, compared to the wild-type. 
4.4 Transport efficiencies of lysine-substrates 
Many studies have examined the effects of single amino acids 
and dipeptides on the growth and performance of animals. For 
example, very recently, the group of Ostaszewska (Ostaszewska et al., 
2012) examined the effects of a Lysine-Glycine-supplemented diet 
(LG) on the nutritional status and digestive tract histology of juvenile 
yellow perch (Perca flavescens). After 48 days of experimental 
feeding, fish fed LG diet showed the highest body mass, highest 
number of gastrin/cholecystokinin positive cells and the lowest 
number of CD3-positive cells; compared to fish on diet without 
supplementation (C), fish on a commercial starter diet (BO) and fish 
on a free lysine and glycine diet (FL).   
According to the authors, the brush border of anterior intestine 





weakest in fish fed C diet. The largest hepatocytes were observed in 
fish fed BO, while the smallest in those fed FL diet, the difference 
being statistically significant. Relative hepatocyte cytoplasm volume 
occupied by lipids was higher in fish fed BO and FL compared to 
those fed C and LG. Number of proliferating cell nuclear antigen-
positive hepatocyte nuclei did not significantly differ among 
experimental groups. The authors concluded that wheat-gluten-
protein-based diets supplemented with dipeptide Lys-Gly (LG) were 
appropriate for yellow perch.  
From our results, KK and KKK did not show high transport 
current with Pept1; perhaps underscoring the importance of charges as 
a factor in PepT1-substrate interactions (Terada et al., 2000). While 
lysine supplementation has been shown to be beneficial (Ostaszewska 
et al., 2010), the effect of the relative position of lysine in dipeptides 
used as feed supplements has not been shown. The fact that lysine-
methionine (KM) and lysine-glycine (KG) showed higher transport 
activities than methionine-lysine (MK) and glycine-lysine (GK) 
respectively in rabbit and seabass isoforms of PepT1 points to the 
importance of the position of lysine in a dipeptide formation. 
However it is not known whether this effect is limited to 
dipeptides where lysine is coupled to a neutral amino acid. Although 
these results show in general terms that rabbit and seabass PepT1s 
have higher affinities for a lysine-methionine dipeptide, it probably 
may not translate into a huge commercial advantage in rabbit breeding 
because both lysine and methionine, either as single amino acids or as 
a dipeptide, have been shown to increase hypercholesterolemia in 





however be reduced by arginine supplementation. The zebra fish 
isoform does not appear to discriminate between transport of lysine-
methionine and methionine-lysine based on the position of the lysine, 
although it preferentially transports more KG than GK; quite like 
other isoforms tested. This lack of discrimination might reflect a 
specie difference. 
PepT1 is a proton-coupled transporter, and as pointed out in 
Figure 3.1, its operation is affected by extracellular pH. The potency 
order of all the substrates tested is the same in all species regardless of 
the pH. Therefore the observed differences among the substrates 
might not be as a result of a change in pH. All the PepT1 isoforms 
exhibit low affinities for KK and KKK. In terms of transport 
efficiencies, in seabass and rabbit, KM and KG have the highest; with 
KK and GK having the lowest. The transport preference favours those 
substrates which improve transport efficiency over those that reduce 
it. A similar trend of preference is seen in zfPepT1 in which relatively 
high affinity and excellent transport efficiency were shown by Met-






CHAPTER 5 CONCLUSIONS 
 
In this work, electrophysiological techniques have been used to 
study some functional aspects of the peptide transporter (PepT1), and 
a number of interesting contributions have been made to our 
knowledge of this transporter. 
Rise in temperature 20 to 30 °C causes an increase in the 
maximal transport-associated current (Imax) with a Q10 close to 4 and 
also accelerates the rate of decline of the presteady-state currents 
observed in the absence of organic substrate. The voltage dependence 
of the intramembrane charge movement (Qin) and of the time constant 
of decline () are both shifted towards more negative potentials by 
higher temperatures.  
The shift is due to a differential effect of temperature on the 
unidirectional rates of charge movement. The temperature effect is 
stronger on the outward rate of charge movement compared to the 
inward; indicating a lower activation energy for the latter process. 
Consistently, the activation energy for the complete cycle is similar to 
that of the inward rate of charge movement. Temperature also affects 
the apparent affinity for the substrate: the K0.5 – V curve is shifted to 
more negative potentials by higher temperatures, resulting in a lower 
apparent affinity in the physiological range of potentials. The overall 
efficiency of transport, estimated as the Imax/K0.5 ratio is also 
significantly increased at higher temperatures. 
With respect to the rabbit pepT1, the observed effects of 





transporter becomes qualitatively and quantitatively similar to its fish 
counterpart when both are examined at their physiological body 
temperature. In line with this, it is proposed that there would be 
specific amino acid residues that confer some form of thermal 
flexibility on the transporter. Furthermore, the detailed analysis of the 
biophysical parameters reveals interesting correlations between the 
thermodynamics requirements of the different transitions in the 
transport cycle, as well as a significant decrease in the apparent 
substrate affinity at higher temperatures. Since this last effect appears 
to be a direct result of the accelerated turnover rate, it is expected to 
be a common feature of ion-coupled cotransporters (Beckman & 
Quick, 2001), and it may be expected to occur for other transporters, 
with relevant consequences on their physiological functioning. 
Mutants in the putative charge pair residues Arg282 and 
Asp341 of rabbit PepT1 have been shown to exhibit properties useful 
to better understand the possibility of reverse transport. In fact, wild-
type and Arg282 mutants, while retaining the essential characteristics 
of proton-coupled cotransporters, exhibit outward currents in the 
presence of Gly-Gln. Long-lasting voltage- and current-clamp 
experiments have shown that these currents are only temporary, and 
reflect accumulation and/or depletion effects near the membrane.  
The reversal potential of the outward currents is affected by 
both pH and substrate concentration, confirming coupled transport in 
the wild-type and in the mutants as well. Removal of arginine 282 
appears to facilitate the flow of the transported complex in both 
directions, while replacement of aspartate 341 with a positive residue 





characteristics of the wild-type transporter. This observation is 
consistent with the idea of these two residues being part of the gate 
controlling the flux of inward positive charges. 
For the benefit of optimizing animal feed, different lysine-
containing dipeptides have been tested. In all isoforms the substrate 
potency order was pH-independent in the range 6.5 -7.5, and the 
tripeptide Lys-Lys-Lys did not give rise to any current. In rabbit and 
seabass PepT1s, the dipeptide Lys-Lys was only modestly transported 
at all voltages, while in the zebrafish a strong current increase was 
observed at negative membrane potentials. 
Transport efficiency data in the seabass and rabbit PepT1s 
show the importance of the position of lysine in the dipeptide; being 
higher when lysine in the first position. These proteins have very low 
affinity for dipeptides Lys-Lys and Gly-Lys which highly reduce the 
transport efficiency. Other dipeptides tested were quite similar in 
affinity (between 0.2-0.8 mM) with small changes with voltage, but 
the transport efficiency was significantly higher for Lys-Met and Lys-
Gly. In zfPepT1 relatively high affinity and excellent transport 
efficiency were shown by Met-Lys and Lys-Met, while low efficiency 
was found for Gly-Lys. This result may be useful in the 
supplementation with essential amino acids. 
In summary, the studies reported in this thesis have contributed to 
a better understanding of the mode of transport by PepT1. Since the 
transporter is of great interest in basic science, pharmacology and drug 
design, and animal husbandry, the detailed information generated 
from this work would complement what is already known to drug 





others to study the transporter more. My studies have generated some 
new hypotheses for further studies; and asides adding to the existing 
pool of literature on the subject matter, the studies have also raised 
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